{"recordsFiltered":49280,"recordsTotal":49280,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=-status&start=20100","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=-status&start=19500","results":[{"registry_id":"NCT04700189","publication_url":"https://clinicaltrials.gov/study/NCT04700189","title":"A First in Human Clinical Trial to Evaluate the Safety and Effectiveness of the STREAMLINE™ SURGICAL SYSTEM in Patients With Open-Angle Glaucoma","has_exemption":false,"start_date":"2020-12-04","completion_date":"2022-09-21","has_results":false,"results_due":true,"sponsor_name":"New World Medical, Inc.","sponsor_slug":"new-world-medical-inc","status":"reported-late","is_pact":false,"days_late":578},{"registry_id":"NCT04879628","publication_url":"https://clinicaltrials.gov/study/NCT04879628","title":"A Phase 2, Double-blind, Randomized, Placebo-controlled Study Assessing Efficacy and Safety of SAR441344, a CD40L-antagonist Monoclonal Antibody, in Participants With Relapsing Multiple Sclerosis","has_exemption":true,"start_date":"2021-06-07","completion_date":"2022-09-21","has_results":true,"results_due":true,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04969198","publication_url":"https://clinicaltrials.gov/study/NCT04969198","title":"UW Withdraw From Tobacco Study: Enhancing and Evaluating Tobacco Withdrawal Assessment Psychometrics and Validity","has_exemption":false,"start_date":"2021-07-13","completion_date":"2022-09-21","has_results":true,"results_due":true,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04729595","publication_url":"https://clinicaltrials.gov/study/NCT04729595","title":"A Phase 2/3, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effects of Tempol (MBM-02) in Subjects With COVID-19 Infection","has_exemption":false,"start_date":"2021-09-01","completion_date":"2022-09-21","has_results":false,"results_due":true,"sponsor_name":"Adamis Pharmaceuticals Corporation","sponsor_slug":"adamis-pharmaceuticals-corporation","status":"overdue","is_pact":false,"days_late":1009},{"registry_id":"NCT04560166","publication_url":"https://clinicaltrials.gov/study/NCT04560166","title":"Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor in Combination With Irinotecan and Temozolomide in Patients With High-Risk Neuroblastoma With Primary Refractory Disease or in First Relapse. An International, Single-Arm, Multicenter Phase 2 Trial.","has_exemption":false,"start_date":"2021-11-08","completion_date":"2022-09-21","has_results":true,"results_due":true,"sponsor_name":"Y-mAbs Therapeutics","sponsor_slug":"y-mabs-therapeutics","status":"reported-late","is_pact":false,"days_late":140},{"registry_id":"NCT05228132","publication_url":"https://clinicaltrials.gov/study/NCT05228132","title":"A Prospective, Multi-Center, Single-Arm Clinical Study of the Pristine™ Long-Term Hemodialysis Catheter","has_exemption":false,"start_date":"2022-05-16","completion_date":"2022-09-21","has_results":true,"results_due":true,"sponsor_name":"C. R. Bard","sponsor_slug":"c-r-bard","status":"reported-late","is_pact":false,"days_late":90},{"registry_id":"NCT03384654","publication_url":"https://clinicaltrials.gov/study/NCT03384654","title":"An Open-label, Multicenter, Phase 2 Study Evaluating the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Subjects >=1 and <=30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma","has_exemption":false,"start_date":"2018-05-14","completion_date":"2022-09-22","has_results":true,"results_due":true,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03323151","publication_url":"https://clinicaltrials.gov/study/NCT03323151","title":"A Phase I/II Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma","has_exemption":false,"start_date":"2018-08-13","completion_date":"2022-09-22","has_results":true,"results_due":true,"sponsor_name":"PrECOG, LLC.","sponsor_slug":"precog-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03633799","publication_url":"https://clinicaltrials.gov/study/NCT03633799","title":"A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate VeraCept®, a Long-Acting Reversible Intrauterine Contraceptive for Contraceptive Efficacy, Safety, and Tolerability","has_exemption":false,"start_date":"2018-08-22","completion_date":"2022-09-22","has_results":true,"results_due":true,"sponsor_name":"Sebela Women's Health Inc.","sponsor_slug":"sebela-womens-health-inc","status":"reported-late","is_pact":false,"days_late":648},{"registry_id":"NCT03783689","publication_url":"https://clinicaltrials.gov/study/NCT03783689","title":"The SNAP Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Neuropathic Post-Amputation Pain in a Randomized, Double-blinded, Placebo-controlled, Multicenter Trial","has_exemption":false,"start_date":"2018-12-18","completion_date":"2022-09-22","has_results":true,"results_due":true,"sponsor_name":"SPR Therapeutics, Inc.","sponsor_slug":"spr-therapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03915951","publication_url":"https://clinicaltrials.gov/study/NCT03915951","title":"A Phase 2, Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2019-06-04","completion_date":"2022-09-22","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03972397","publication_url":"https://clinicaltrials.gov/study/NCT03972397","title":"Intercostal Nerve Cryoablation for Postoperative Pain Management","has_exemption":false,"start_date":"2019-07-15","completion_date":"2022-09-22","has_results":true,"results_due":true,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03861988","publication_url":"https://clinicaltrials.gov/study/NCT03861988","title":"Double-blind Trial of Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac Surgery","has_exemption":false,"start_date":"2019-08-22","completion_date":"2022-09-22","has_results":true,"results_due":true,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02855268","publication_url":"https://clinicaltrials.gov/study/NCT02855268","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of Lademirsen (SAR339375) for Subcutaneous Injection Administered Every Week in Patients With Alport Syndrome","has_exemption":false,"start_date":"2019-11-02","completion_date":"2022-09-22","has_results":true,"results_due":true,"sponsor_name":"Genzyme, a Sanofi Company","sponsor_slug":"genzyme-a-sanofi-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04410445","publication_url":"https://clinicaltrials.gov/study/NCT04410445","title":"A Phase 3, Randomized, Open-label Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence (PIVOT-12)","has_exemption":false,"start_date":"2020-07-27","completion_date":"2022-09-22","has_results":true,"results_due":true,"sponsor_name":"Nektar Therapeutics","sponsor_slug":"nektar-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03471507","publication_url":"https://clinicaltrials.gov/study/NCT03471507","title":"Efficacy of a Topical Pain Relief Spray Containing Herbal Oil Extracts (Bonipar) Among Individuals With Acute and Chronic Musculoskeletal Pain","has_exemption":false,"start_date":"2020-12-15","completion_date":"2022-09-22","has_results":true,"results_due":true,"sponsor_name":"Winston Parris, MD","sponsor_slug":"winston-parris-md","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05562011","publication_url":"https://clinicaltrials.gov/study/NCT05562011","title":"A Pilot Feasibility Study of an Ambulatory Multi-Vital Signs Monitor in Perioperative Patients","has_exemption":false,"start_date":"2021-08-18","completion_date":"2022-09-22","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported-late","is_pact":false,"days_late":18},{"registry_id":"NCT05133180","publication_url":"https://clinicaltrials.gov/study/NCT05133180","title":"A 4-week, Phase III, Multicenter, Double-masked, Vehicle-controlled Clinical Study to Evaluate Safety and Efficacy of Oxervate® (Cenegermin) 20 mcg/mL Ophthalmic Solution vs Vehicle in Severe Sjogren's Dry Eye Disease","has_exemption":false,"start_date":"2022-01-19","completion_date":"2022-09-22","has_results":true,"results_due":true,"sponsor_name":"Dompé Farmaceutici S.p.A","sponsor_slug":"dompe-farmaceutici-spa","status":"reported-late","is_pact":false,"days_late":167},{"registry_id":"NCT03542682","publication_url":"https://clinicaltrials.gov/study/NCT03542682","title":"The Effect of Insulin Bolus Speed of Rapid-Acting Insulin Analog Absorption and Action in Individuals With Type 1 Diabetes","has_exemption":true,"start_date":"2018-05-30","completion_date":"2022-09-23","has_results":true,"results_due":true,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03443973","publication_url":"https://clinicaltrials.gov/study/NCT03443973","title":"A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of Gantenerumab in Patients With Early (Prodromal to Mild) Alzheimer's Disease","has_exemption":false,"start_date":"2018-08-22","completion_date":"2022-09-23","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03861767","publication_url":"https://clinicaltrials.gov/study/NCT03861767","title":"Randomized, Embedded, Multifactorial, Adaptive Platform Trial for Optimizing Surgical Outcomes at UPMC","has_exemption":true,"start_date":"2019-04-15","completion_date":"2022-09-23","has_results":true,"results_due":true,"sponsor_name":"Matthew Neal MD","sponsor_slug":"matthew-neal-md","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06586788","publication_url":"https://clinicaltrials.gov/study/NCT06586788","title":"Validation of Indiana's Early Neurodevelopmental Evaluation Hub Program","has_exemption":false,"start_date":"2019-06-07","completion_date":"2022-09-23","has_results":true,"results_due":true,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"reported-late","is_pact":false,"days_late":377},{"registry_id":"NCT04212299","publication_url":"https://clinicaltrials.gov/study/NCT04212299","title":"A Pilot Clinical Trial to Assess the Effect of Transfemoral Socket Design on Hip Muscle Function","has_exemption":false,"start_date":"2019-09-24","completion_date":"2022-09-23","has_results":true,"results_due":true,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"reported-late","is_pact":false,"days_late":180},{"registry_id":"NCT04486326","publication_url":"https://clinicaltrials.gov/study/NCT04486326","title":"Crofelemer for Functional Diarrhea","has_exemption":false,"start_date":"2020-08-20","completion_date":"2022-09-23","has_results":true,"results_due":true,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"reported-late","is_pact":false,"days_late":625},{"registry_id":"NCT04618211","publication_url":"https://clinicaltrials.gov/study/NCT04618211","title":"A Phase II, Double-blind, Placebo-controlled, Randomized, Cross-over, Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema Due to C1-inhibitor Deficiency Type I and II","has_exemption":true,"start_date":"2021-02-03","completion_date":"2022-09-23","has_results":true,"results_due":true,"sponsor_name":"Pharvaris Netherlands B.V.","sponsor_slug":"pharvaris-netherlands-bv","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04932928","publication_url":"https://clinicaltrials.gov/study/NCT04932928","title":"Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients","has_exemption":false,"start_date":"2021-03-23","completion_date":"2022-09-23","has_results":false,"results_due":true,"sponsor_name":"Seoul National University Hospital","sponsor_slug":"seoul-national-university-hospital","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05013905","publication_url":"https://clinicaltrials.gov/study/NCT05013905","title":"A Phase 2a, Multi-Center, Open-Label Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of PRA023 in Subjects With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2021-07-28","completion_date":"2022-09-23","has_results":true,"results_due":true,"sponsor_name":"Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","sponsor_slug":"prometheus-biosciences-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05030350","publication_url":"https://clinicaltrials.gov/study/NCT05030350","title":"A Phase 3 Open-label Safety Trial of PH94B Nasal Spray in the Acute Treatment of Anxiety in Adult Subjects With Social Anxiety Disorder (SAD)","has_exemption":true,"start_date":"2021-10-01","completion_date":"2022-09-23","has_results":true,"results_due":true,"sponsor_name":"VistaGen Therapeutics, Inc.","sponsor_slug":"vistagen-therapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05162066","publication_url":"https://clinicaltrials.gov/study/NCT05162066","title":"An Open-Label, Safety, Tolerability, and Proof-of-Concept Study of Oral BCX9930 Therapy in Subjects With Complement 3 Glomerulopathy, Immunoglobulin A Nephropathy, or Primary Membranous Nephropathy","has_exemption":false,"start_date":"2022-02-18","completion_date":"2022-09-23","has_results":true,"results_due":true,"sponsor_name":"BioCryst Pharmaceuticals","sponsor_slug":"biocryst-pharmaceuticals","status":"reported-late","is_pact":false,"days_late":198},{"registry_id":"NCT04906980","publication_url":"https://clinicaltrials.gov/study/NCT04906980","title":"A Phase 2a, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Antiviral Activity, Safety and Tolerability, and Pharmacokinetics of JNJ-64281802 in Participants With Confirmed Dengue Fever","has_exemption":false,"start_date":"2022-01-24","completion_date":"2022-09-24","has_results":true,"results_due":true,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"reported-late","is_pact":false,"days_late":134},{"registry_id":"NCT04057365","publication_url":"https://clinicaltrials.gov/study/NCT04057365","title":"A Single Arm Phase II Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC)","has_exemption":false,"start_date":"2019-10-07","completion_date":"2022-09-25","has_results":true,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"reported-late","is_pact":false,"days_late":171},{"registry_id":"NCT03052049","publication_url":"https://clinicaltrials.gov/study/NCT03052049","title":"Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)","has_exemption":false,"start_date":"2017-09-06","completion_date":"2022-09-26","has_results":true,"results_due":true,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03555149","publication_url":"https://clinicaltrials.gov/study/NCT03555149","title":"A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC)","has_exemption":false,"start_date":"2018-09-27","completion_date":"2022-09-26","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04558918","publication_url":"https://clinicaltrials.gov/study/NCT04558918","title":"A Randomized, Multicenter, Active-comparator Controlled, Open-label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily LNP023 in Adult Patients With PNH and Residual Anemia, Despite Treatment With an Intravenous Anti-C5 Antibody.","has_exemption":false,"start_date":"2021-01-25","completion_date":"2022-09-26","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04826939","publication_url":"https://clinicaltrials.gov/study/NCT04826939","title":"Validity (and Reliability) of Two Forms of an Accelerometer-Based Intravaginal Device for Detecting Pelvic Floor Motion","has_exemption":false,"start_date":"2021-03-25","completion_date":"2022-09-26","has_results":false,"results_due":true,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"reported-late","is_pact":false,"days_late":245},{"registry_id":"NCT05411861","publication_url":"https://clinicaltrials.gov/study/NCT05411861","title":"Randomized, Double-Blind, Placebo- and Active-Controlled, Dose Escalation and Optional Dose Expansion Study to Evaluate Safety, Efficacy, and PK of CPL-01 in Post-Op Pain After Unilateral Distal First Metatarsal Bunionectomy + Osteotomy","has_exemption":false,"start_date":"2022-06-14","completion_date":"2022-09-26","has_results":false,"results_due":true,"sponsor_name":"Cali Pharmaceuticals LLC","sponsor_slug":"cali-pharmaceuticals-llc","status":"overdue","is_pact":false,"days_late":1004},{"registry_id":"NCT05833100","publication_url":"https://clinicaltrials.gov/study/NCT05833100","title":"Method Comparison/User Evaluation of the i-SENS Self-Monitoring Blood Glucose / β-Ketone System (CareSens PRO GK BT)","has_exemption":false,"start_date":"2022-08-15","completion_date":"2022-09-26","has_results":true,"results_due":true,"sponsor_name":"i-SENS, Inc.","sponsor_slug":"i-sens-inc","status":"reported-late","is_pact":false,"days_late":77},{"registry_id":"NCT02261883","publication_url":"https://clinicaltrials.gov/study/NCT02261883","title":"Intravenous Remodulin (Treprostinil) as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Randomized, Placebo-Controlled, Safety and Efficacy Study","has_exemption":false,"start_date":"2015-07-29","completion_date":"2022-09-27","has_results":true,"results_due":true,"sponsor_name":"United Therapeutics","sponsor_slug":"united-therapeutics","status":"reported-late","is_pact":true,"days_late":104},{"registry_id":"NCT02536300","publication_url":"https://clinicaltrials.gov/study/NCT02536300","title":"Dose Optimization Study of Idelalisib in Follicular Lymphoma","has_exemption":false,"start_date":"2016-01-14","completion_date":"2022-09-27","has_results":true,"results_due":true,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02923739","publication_url":"https://clinicaltrials.gov/study/NCT02923739","title":"A Randomized Phase II Induction Discontinuation Trial of Emactuzumab Following Paclitaxel and Bevacizumab in Patients With Platinum-Resistant, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","has_exemption":false,"start_date":"2017-05-05","completion_date":"2022-09-27","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03719131","publication_url":"https://clinicaltrials.gov/study/NCT03719131","title":"A Randomized Phase 2 Study of Rituxan Hycela in Patients With Advanced Melanoma Undergoing Combination Immune Checkpoint Blockade With Nivolumab and Ipilimumab","has_exemption":false,"start_date":"2019-06-05","completion_date":"2022-09-27","has_results":true,"results_due":true,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"reported-late","is_pact":false,"days_late":533},{"registry_id":"NCT04085523","publication_url":"https://clinicaltrials.gov/study/NCT04085523","title":"ACcomplisH: A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of Subcutaneous Doses of TransCon CNP Administered Once Weekly for 52 Weeks in Prepubertal Children With Achondroplasia Followed by an Open-Label Extension Period","has_exemption":false,"start_date":"2020-06-24","completion_date":"2022-09-27","has_results":true,"results_due":true,"sponsor_name":"Ascendis Pharma A/S","sponsor_slug":"ascendis-pharma-as","status":"reported-late","is_pact":false,"days_late":91},{"registry_id":"NCT05124873","publication_url":"https://clinicaltrials.gov/study/NCT05124873","title":"Moisture Management Liner At-Home Evaluation","has_exemption":false,"start_date":"2021-05-12","completion_date":"2022-09-27","has_results":true,"results_due":true,"sponsor_name":"Liberating Technologies, Inc.","sponsor_slug":"liberating-technologies-inc","status":"reported-late","is_pact":false,"days_late":567},{"registry_id":"NCT04956575","publication_url":"https://clinicaltrials.gov/study/NCT04956575","title":"A Phase 1/2, Randomized, Stratified, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults 18 Years and Older","has_exemption":false,"start_date":"2021-07-06","completion_date":"2022-09-27","has_results":true,"results_due":true,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04771611","publication_url":"https://clinicaltrials.gov/study/NCT04771611","title":"COVFIS-HOME: A Phase 2 Placebo-Controlled Pilot Study in COVID-19 of Fisetin to Alleviate Dysfunction and Decrease Complications in At-Risk Outpatients","has_exemption":false,"start_date":"2021-07-14","completion_date":"2022-09-27","has_results":true,"results_due":true,"sponsor_name":"James L. Kirkland, MD, PhD","sponsor_slug":"james-l-kirkland-md-phd","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05196828","publication_url":"https://clinicaltrials.gov/study/NCT05196828","title":"Open-label Extension Study to Evaluate Longer-Duration Response to the NTX100 Neuromodulation System for Patients With Medication-Refractory Primary Restless Legs Syndrome (RLS)","has_exemption":false,"start_date":"2021-12-20","completion_date":"2022-09-27","has_results":true,"results_due":true,"sponsor_name":"Noctrix Health, Inc.","sponsor_slug":"noctrix-health-inc","status":"reported-late","is_pact":false,"days_late":61},{"registry_id":"NCT01867333","publication_url":"https://clinicaltrials.gov/study/NCT01867333","title":"A Randomized Phase II Trial Combining Vaccine Therapy With PROSTVAC /TRICOM and Enzalutamide vs. Enzalutamide Alone in Men With Metastatic Castration Resistant Prostate Cancer","has_exemption":false,"start_date":"2013-08-12","completion_date":"2022-09-28","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02564978","publication_url":"https://clinicaltrials.gov/study/NCT02564978","title":"Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration","has_exemption":false,"start_date":"2016-12-14","completion_date":"2022-09-28","has_results":true,"results_due":true,"sponsor_name":"National Eye Institute (NEI)","sponsor_slug":"national-eye-institute-nei","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03976102","publication_url":"https://clinicaltrials.gov/study/NCT03976102","title":"A Double-blind, Parallel-group, Phase III Study to Compare the Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in Subjects With Previously Untreated (CD)20-Positive LTB Follicular Lymphoma","has_exemption":false,"start_date":"2019-05-15","completion_date":"2022-09-28","has_results":true,"results_due":true,"sponsor_name":"Dr. Reddy's Laboratories Limited","sponsor_slug":"dr-reddys-laboratories-limited","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03905525","publication_url":"https://clinicaltrials.gov/study/NCT03905525","title":"A 48-week, 6-arm, Randomized, Double-blind, Placebo-controlled Multicenter Trial to Assess the Safety and Efficacy of Multiple CFZ533 Doses Administered Subcutaneously in Two Distinct Populations of Patients With Sjogren's Syndrome (TWINSS)","has_exemption":true,"start_date":"2019-10-01","completion_date":"2022-09-28","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04187196","publication_url":"https://clinicaltrials.gov/study/NCT04187196","title":"Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion","has_exemption":false,"start_date":"2020-04-29","completion_date":"2022-09-28","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported-late","is_pact":false,"days_late":20},{"registry_id":"NCT03670849","publication_url":"https://clinicaltrials.gov/study/NCT03670849","title":"Ultrasound Augmentation of Stereoscopic and Conventional Video for Laparoscopic Surgeries","has_exemption":false,"start_date":"2020-09-29","completion_date":"2022-09-28","has_results":false,"results_due":true,"sponsor_name":"Raj Shekhar","sponsor_slug":"raj-shekhar","status":"overdue","is_pact":false,"days_late":1002},{"registry_id":"NCT04471428","publication_url":"https://clinicaltrials.gov/study/NCT04471428","title":"A Phase III, Multicenter, Randomized, Open-Label, Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Atezolizumab Given in Combination With Cabozantinib Versus Docetaxel Monotherapy in Patients With Metastatic Non-Small Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy","has_exemption":false,"start_date":"2020-10-01","completion_date":"2022-09-28","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04395222","publication_url":"https://clinicaltrials.gov/study/NCT04395222","title":"A Prospective Study of Tocilizumab for the Prevention of Graft Failure and Graft-versus-Host Disease in Haplo-Cord Transplantation","has_exemption":false,"start_date":"2020-10-07","completion_date":"2022-09-28","has_results":true,"results_due":true,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04614467","publication_url":"https://clinicaltrials.gov/study/NCT04614467","title":"A Double-Blind, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of CLBS16 in Subjects With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease","has_exemption":true,"start_date":"2020-10-29","completion_date":"2022-09-28","has_results":true,"results_due":true,"sponsor_name":"Lisata Therapeutics, Inc.","sponsor_slug":"lisata-therapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04684511","publication_url":"https://clinicaltrials.gov/study/NCT04684511","title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase III Study With a Long-Term, Open-Label Extension to Evaluate the Efficacy and Safety of TRM-201 (Rofecoxib) in Patients With Hemophilic Arthropathy","has_exemption":false,"start_date":"2021-06-02","completion_date":"2022-09-28","has_results":false,"results_due":true,"sponsor_name":"Tremeau Pharmceuticals, Inc.","sponsor_slug":"tremeau-pharmceuticals-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04892706","publication_url":"https://clinicaltrials.gov/study/NCT04892706","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Clinical Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel (0.3% Adapalene/2.5% BPO), in the Treatment of Acne Vulgaris","has_exemption":true,"start_date":"2021-06-11","completion_date":"2022-09-28","has_results":true,"results_due":true,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05713864","publication_url":"https://clinicaltrials.gov/study/NCT05713864","title":"Evaluation of the Combination Treatment With BTL-899 and HPM-6000UF Devices for Abdominal and Pelvic Floor Muscle Strengthening and Overall Improvement in Quality of Life in Patients After Childbirth","has_exemption":false,"start_date":"2022-03-08","completion_date":"2022-09-28","has_results":false,"results_due":true,"sponsor_name":"BTL Industries Ltd.","sponsor_slug":"btl-industries-ltd","status":"overdue","is_pact":false,"days_late":1002},{"registry_id":"NCT05768893","publication_url":"https://clinicaltrials.gov/study/NCT05768893","title":"Evaluation of Combined Treatment With Er:YAG Laser and Long-pulsed Nd:YAG Laser for the Treatment of Recalcitrant Warts: a Prospective Randomized Controlled Trial","has_exemption":false,"start_date":"2022-05-01","completion_date":"2022-09-28","has_results":false,"results_due":true,"sponsor_name":"Rambam Health Care Campus","sponsor_slug":"rambam-health-care-campus","status":"overdue","is_pact":false,"days_late":1002},{"registry_id":"NCT05226104","publication_url":"https://clinicaltrials.gov/study/NCT05226104","title":"Investigating the Efficacy of a Fractionated 1927nm Laser for Diffuse Pigmentation and Actinic Changes","has_exemption":false,"start_date":"2022-05-18","completion_date":"2022-09-28","has_results":true,"results_due":true,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05229445","publication_url":"https://clinicaltrials.gov/study/NCT05229445","title":"Safety of a Real-time Continuous Glucose Monitor-based Insulin Bolus Calculator: The \"CGM-IBC\" Study","has_exemption":false,"start_date":"2022-07-05","completion_date":"2022-09-28","has_results":false,"results_due":true,"sponsor_name":"Welldoc","sponsor_slug":"welldoc","status":"overdue","is_pact":false,"days_late":1002},{"registry_id":"NCT02437136","publication_url":"https://clinicaltrials.gov/study/NCT02437136","title":"A Phase 1b/2, Open-label, Dose Escalation Study of Entinostat in Combination With Pembrolizumab in Patients With Non-small Cell Lung Cancer, With Expansion Cohorts in Patients With Non-small Cell Lung Cancer, Melanoma, and Mismatch Repair-Proficient Colorectal Cancer","has_exemption":true,"start_date":"2015-08-26","completion_date":"2022-09-29","has_results":true,"results_due":true,"sponsor_name":"Syndax Pharmaceuticals","sponsor_slug":"syndax-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03030261","publication_url":"https://clinicaltrials.gov/study/NCT03030261","title":"A Phase II Study of Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma","has_exemption":false,"start_date":"2017-11-22","completion_date":"2022-09-29","has_results":true,"results_due":true,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04102020","publication_url":"https://clinicaltrials.gov/study/NCT04102020","title":"Multicenter, Phase 3 Study of Venetoclax and Azacitidine as Maintenance Therapy for Patients With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy","has_exemption":true,"start_date":"2020-03-26","completion_date":"2022-09-29","has_results":true,"results_due":true,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04773600","publication_url":"https://clinicaltrials.gov/study/NCT04773600","title":"A Phase 3, 4-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-151 Cream 0.15% Administered QD in Subjects With Atopic Dermatitis","has_exemption":true,"start_date":"2021-02-24","completion_date":"2022-09-29","has_results":true,"results_due":true,"sponsor_name":"Arcutis Biotherapeutics, Inc.","sponsor_slug":"arcutis-biotherapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04573881","publication_url":"https://clinicaltrials.gov/study/NCT04573881","title":"The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK)","has_exemption":false,"start_date":"2021-06-04","completion_date":"2022-09-29","has_results":true,"results_due":true,"sponsor_name":"HistoSonics, Inc.","sponsor_slug":"histosonics-inc","status":"reported-late","is_pact":false,"days_late":167},{"registry_id":"NCT04887298","publication_url":"https://clinicaltrials.gov/study/NCT04887298","title":"Phase 1B/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects with Previously Treated Soft-Tissue Sarcomas with Pulmonary Metastases","has_exemption":false,"start_date":"2021-06-05","completion_date":"2022-09-29","has_results":false,"results_due":true,"sponsor_name":"Moleculin Biotech, Inc.","sponsor_slug":"moleculin-biotech-inc","status":"overdue","is_pact":false,"days_late":1001},{"registry_id":"NCT05605262","publication_url":"https://clinicaltrials.gov/study/NCT05605262","title":"Effects of 100% Medical Grade Manuka Honey on Re-epithelialization Post Tympanoplasty in the Case of Mucosal Type Chronic Suppurative Otitis Media (CSOM) - A Prospective Double-blinded Randomized Controlled Trial","has_exemption":false,"start_date":"2021-06-13","completion_date":"2022-09-29","has_results":false,"results_due":true,"sponsor_name":"Fakultas Kedokteran Universitas Indonesia","sponsor_slug":"fakultas-kedokteran-universitas-indonesia","status":"overdue","is_pact":false,"days_late":1001},{"registry_id":"NCT04756804","publication_url":"https://clinicaltrials.gov/study/NCT04756804","title":"A Randomized, Controlled Clinical Trial Evaluating A Novel Perioperative Patient Skin Antiseptic Preparation","has_exemption":false,"start_date":"2021-06-21","completion_date":"2022-09-29","has_results":true,"results_due":true,"sponsor_name":"Zurex Pharma, Inc.","sponsor_slug":"zurex-pharma-inc","status":"reported-late","is_pact":false,"days_late":117},{"registry_id":"NCT05657717","publication_url":"https://clinicaltrials.gov/study/NCT05657717","title":"Otological Safety Profile of 100% Manuka Honey Application in Tympanoplasty: A Double-blinded Randomized Controlled Trial","has_exemption":false,"start_date":"2021-07-13","completion_date":"2022-09-29","has_results":false,"results_due":true,"sponsor_name":"Fakultas Kedokteran Universitas Indonesia","sponsor_slug":"fakultas-kedokteran-universitas-indonesia","status":"overdue","is_pact":false,"days_late":1001},{"registry_id":"NCT05163353","publication_url":"https://clinicaltrials.gov/study/NCT05163353","title":"Prospective, Multicenter, Controlled, Evaluator-blind, Randomized Study to Investigate the Effectiveness and Safety of Diluted RADIESSE® for Treatment of Décolleté Wrinkles","has_exemption":true,"start_date":"2021-12-10","completion_date":"2022-09-29","has_results":true,"results_due":true,"sponsor_name":"Merz North America, Inc.","sponsor_slug":"merz-north-america-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04588207","publication_url":"https://clinicaltrials.gov/study/NCT04588207","title":"Urea for Chronic Hyponatremia: A Pilot Study","has_exemption":false,"start_date":"2021-12-28","completion_date":"2022-09-29","has_results":true,"results_due":true,"sponsor_name":"Helbert Rondon Berrios, MD, MS","sponsor_slug":"helbert-rondon-berrios-md-ms","status":"reported-late","is_pact":false,"days_late":151},{"registry_id":"NCT05288114","publication_url":"https://clinicaltrials.gov/study/NCT05288114","title":"A Pilot Study of the Signal Relief Patch for the Treatment of Musculoskeletal Pain","has_exemption":false,"start_date":"2022-01-21","completion_date":"2022-09-29","has_results":false,"results_due":true,"sponsor_name":"Signal Relief","sponsor_slug":"signal-relief","status":"reported-late","is_pact":false,"days_late":206},{"registry_id":"NCT05270460","publication_url":"https://clinicaltrials.gov/study/NCT05270460","title":"A Phase 2A, Placebo-controlled, Randomized, Dose Response Study of the Safety, Pharmacokinetics and Efficacy of PCS12852 on Gastric Emptying Rate Assessed by 13C Spirulina GEBT in Patients With Moderate to Severe Gastroparesis","has_exemption":false,"start_date":"2022-03-09","completion_date":"2022-09-29","has_results":true,"results_due":true,"sponsor_name":"Processa Pharmaceuticals","sponsor_slug":"processa-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05087979","publication_url":"https://clinicaltrials.gov/study/NCT05087979","title":"Use of Stable Airway Management Device in Monitored Anesthesia Care","has_exemption":false,"start_date":"2022-07-28","completion_date":"2022-09-29","has_results":true,"results_due":true,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"reported-late","is_pact":false,"days_late":19},{"registry_id":"NCT00966979","publication_url":"https://clinicaltrials.gov/study/NCT00966979","title":"A Prospective, Post-market, Multi-center Study of the Outcomes of the Triathlon® Partial Knee Resurfacing (PKR) Unicondylar Knee System","has_exemption":false,"start_date":"2010-01-31","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Stryker Orthopaedics","sponsor_slug":"stryker-orthopaedics","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01776190","publication_url":"https://clinicaltrials.gov/study/NCT01776190","title":"Low-dose UVA1 Radiation in Cutaneous Lupus Patients","has_exemption":false,"start_date":"2012-09-30","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Ben Chong","sponsor_slug":"ben-chong","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT04106882","publication_url":"https://clinicaltrials.gov/study/NCT04106882","title":"Dynamic Connectivity Under Metabolic Constraints","has_exemption":false,"start_date":"2015-06-19","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Stony Brook University","sponsor_slug":"stony-brook-university","status":"reported-late","is_pact":true,"days_late":234},{"registry_id":"NCT02616172","publication_url":"https://clinicaltrials.gov/study/NCT02616172","title":"Safety of Infusion of Autologous Human Bone Marrow Mononuclear Fraction in Children With Sensorineural Hearing Loss","has_exemption":false,"start_date":"2015-10-31","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"James Baumgartner, MD","sponsor_slug":"james-baumgartner-md","status":"overdue","is_pact":true,"days_late":1000},{"registry_id":"NCT02588027","publication_url":"https://clinicaltrials.gov/study/NCT02588027","title":"Effect of Ibuprofen on Postoperative Opiate Medication Use and Shoulder Functional Outcomes After Arthroscopic Rotator Cuff Repair","has_exemption":false,"start_date":"2015-10-31","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03360942","publication_url":"https://clinicaltrials.gov/study/NCT03360942","title":"Long Term Follow-up of Deep Brain Stimulation for Treatment-Resistant Depression","has_exemption":false,"start_date":"2016-04-18","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"reported-late","is_pact":true,"days_late":306},{"registry_id":"NCT02953392","publication_url":"https://clinicaltrials.gov/study/NCT02953392","title":"Evaluation of Implant-Abutment Interface Design on Bone and Soft Tissue Levels Around Implants Placed Using Two Different Transcrestal Sinus Floor Elevation Approaches: A Multi-Center, Double Blind, Randomized Trial","has_exemption":false,"start_date":"2016-05-10","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"NYU College of Dentistry","sponsor_slug":"nyu-college-of-dentistry","status":"reported-late","is_pact":true,"days_late":439},{"registry_id":"NCT02629393","publication_url":"https://clinicaltrials.gov/study/NCT02629393","title":"A Phase 2/3, Multicenter, Multinational, Open Label Study to Evaluate the Efficacy and Safety of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MOCD) Type A","has_exemption":false,"start_date":"2016-05-31","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Origin Biosciences","sponsor_slug":"origin-biosciences","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02823028","publication_url":"https://clinicaltrials.gov/study/NCT02823028","title":"Social Media Technology for Treating Tobacco Addiction","has_exemption":false,"start_date":"2016-10-31","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"reported-late","is_pact":true,"days_late":329},{"registry_id":"NCT03244475","publication_url":"https://clinicaltrials.gov/study/NCT03244475","title":"Passive Electrical Neurofeedback Treatment of mTBI: MEG and Behavioral Outcomes","has_exemption":false,"start_date":"2017-02-01","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"reported-late","is_pact":false,"days_late":13},{"registry_id":"NCT03291743","publication_url":"https://clinicaltrials.gov/study/NCT03291743","title":"The Biologic Onset of Crohn's Disease: A Screening Study in First Degree Relatives","has_exemption":false,"start_date":"2017-02-10","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Carilion Clinic","sponsor_slug":"carilion-clinic","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT03085485","publication_url":"https://clinicaltrials.gov/study/NCT03085485","title":"A Randomized, Double-blind, Phase 2, Placebo Controlled Study to Determine the Safety and Efficacy of Ivacaftor (VX-770) for the Treatment of Chronic Obstructive Pulmonary Disease (The Topic Trial)","has_exemption":false,"start_date":"2017-03-16","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"reported-late","is_pact":false,"days_late":27},{"registry_id":"NCT03072147","publication_url":"https://clinicaltrials.gov/study/NCT03072147","title":"Evaluating Teriparatide as a Chondroregenerative Therapy in Human Osteoarthritis","has_exemption":false,"start_date":"2017-05-01","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Christopher Ritchlin","sponsor_slug":"christopher-ritchlin","status":"reported-late","is_pact":false,"days_late":535},{"registry_id":"NCT02986178","publication_url":"https://clinicaltrials.gov/study/NCT02986178","title":"A Multicenter Phase 2 Study of Oncolytic Polio/Rhinovirus Recombinant (Lerapolturev) in Recurrent WHO Grade IV Malignant Glioma Patients","has_exemption":false,"start_date":"2017-06-01","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Istari Oncology, Inc.","sponsor_slug":"istari-oncology-inc","status":"reported-late","is_pact":false,"days_late":508},{"registry_id":"NCT03238248","publication_url":"https://clinicaltrials.gov/study/NCT03238248","title":"A Phase II Trial of Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors","has_exemption":false,"start_date":"2017-08-07","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Vanderbilt-Ingram Cancer Center","sponsor_slug":"vanderbilt-ingram-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03153969","publication_url":"https://clinicaltrials.gov/study/NCT03153969","title":"A Clinical Trial to Evaluate a New Giomer Restorative System in Class V Restorations","has_exemption":false,"start_date":"2017-08-28","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Tufts University","sponsor_slug":"tufts-university","status":"reported-late","is_pact":false,"days_late":613},{"registry_id":"NCT03189381","publication_url":"https://clinicaltrials.gov/study/NCT03189381","title":"A Pilot Phase 2 Study Evaluating Dose De-escalation in Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain Metastases","has_exemption":false,"start_date":"2017-09-21","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"reported-late","is_pact":false,"days_late":178},{"registry_id":"NCT03151707","publication_url":"https://clinicaltrials.gov/study/NCT03151707","title":"The Effects of Nicotinamide Riboside Supplementation on Nicotinamide Adenine Dinucleotide (NAD+/NADH) Ratio and Bioenergetics","has_exemption":false,"start_date":"2017-10-01","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Mclean Hospital","sponsor_slug":"mclean-hospital","status":"reported-late","is_pact":false,"days_late":103},{"registry_id":"NCT03245151","publication_url":"https://clinicaltrials.gov/study/NCT03245151","title":"A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including CNS Tumors","has_exemption":false,"start_date":"2017-11-16","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Eisai Inc.","sponsor_slug":"eisai-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03304418","publication_url":"https://clinicaltrials.gov/study/NCT03304418","title":"A Phase 2 Study of Radium-223 and Radiotherapy in Hormone-Naïve Men With Oligometastatic Prostate Cancer to Bone","has_exemption":false,"start_date":"2018-02-27","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"reported-late","is_pact":false,"days_late":19},{"registry_id":"NCT03473743","publication_url":"https://clinicaltrials.gov/study/NCT03473743","title":"A Phase 1b-2 Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Various Regimens of Erdafitinib in Subjects With Metastatic or Locally Advanced Urothelial Cancer","has_exemption":false,"start_date":"2018-04-05","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03398200","publication_url":"https://clinicaltrials.gov/study/NCT03398200","title":"HBO Effects on Blood Count Recovery and Post-transplant Outcomes Following High-dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma","has_exemption":false,"start_date":"2018-05-10","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Omar Aljitawi","sponsor_slug":"omar-aljitawi","status":"reported-late","is_pact":false,"days_late":10},{"registry_id":"NCT03272685","publication_url":"https://clinicaltrials.gov/study/NCT03272685","title":"Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace Part of \"Evaluating New Nicotine Standards for Cigarettes\"","has_exemption":false,"start_date":"2018-06-01","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"reported-late","is_pact":false,"days_late":23},{"registry_id":"NCT04035460","publication_url":"https://clinicaltrials.gov/study/NCT04035460","title":"A Pilot Randomized Controlled Study of Non-invasive Oxygenation and Ventilation in Patients With Acute Hypoxemic Respiratory Failure (AHRF): A Comparison of Oxygen Delivery Via Helmet Interface Versus High Flow Nasal Cannula (HFNC)","has_exemption":false,"start_date":"2018-06-01","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Baystate Medical Center","sponsor_slug":"baystate-medical-center","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT03545607","publication_url":"https://clinicaltrials.gov/study/NCT03545607","title":"MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2)","has_exemption":false,"start_date":"2018-07-28","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Healios K.K.","sponsor_slug":"healios-kk","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT03696953","publication_url":"https://clinicaltrials.gov/study/NCT03696953","title":"The Efficacy of Probiotics to Reduce Antepartum Group B Streptococcus Colonization","has_exemption":false,"start_date":"2019-02-01","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Marquette University","sponsor_slug":"marquette-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03872856","publication_url":"https://clinicaltrials.gov/study/NCT03872856","title":"Home Blood Pressure Monitoring Intervention for Self-Management of High Blood Pressure Among Alaska Native People","has_exemption":false,"start_date":"2019-02-19","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Southcentral Foundation","sponsor_slug":"southcentral-foundation","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT03489018","publication_url":"https://clinicaltrials.gov/study/NCT03489018","title":"The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines (PCV10 and PCV13) on Immunogenicity and Vaccine-serotype Carriage in Kenyan Infants","has_exemption":false,"start_date":"2019-03-21","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"London School of Hygiene and Tropical Medicine","sponsor_slug":"london-school-of-hygiene-and-tropical-medicine","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT03414762","publication_url":"https://clinicaltrials.gov/study/NCT03414762","title":"PICO Negative Pressure Wound Therapy in Obese Women Undergoing Elective Cesarean Delivery.","has_exemption":false,"start_date":"2019-04-01","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT03859973","publication_url":"https://clinicaltrials.gov/study/NCT03859973","title":"A Phase II Randomized, Double-blinded, Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of BI 425809 Once Daily With Adjunctive Computerized Cognitive Training Over 12 Week Treatment Period in Patients With Schizophrenia","has_exemption":true,"start_date":"2019-04-15","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03812991","publication_url":"https://clinicaltrials.gov/study/NCT03812991","title":"The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring Injuries","has_exemption":false,"start_date":"2019-07-01","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"reported-late","is_pact":false,"days_late":184},{"registry_id":"NCT04139213","publication_url":"https://clinicaltrials.gov/study/NCT04139213","title":"Comparing Medication Maintenance in Comprehensive Community and Pharmacy Settings to Enhance Engagement","has_exemption":false,"start_date":"2019-07-25","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Lifespan","sponsor_slug":"lifespan","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT04143451","publication_url":"https://clinicaltrials.gov/study/NCT04143451","title":"Intradermal Quadrivalent Influenza Vaccine With Topical Imiquimod in Elderly & Chronic Ill Subjects, a Double-Blind Randomized Controlled Trial","has_exemption":false,"start_date":"2019-10-23","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"The University of Hong Kong","sponsor_slug":"the-university-of-hong-kong","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT04118829","publication_url":"https://clinicaltrials.gov/study/NCT04118829","title":"Correlation of Serum Level of Perampanel (PER) Level to Cerebrospinal Fluid (CSF) Levels of PER","has_exemption":false,"start_date":"2019-11-01","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Carilion Clinic","sponsor_slug":"carilion-clinic","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT06118944","publication_url":"https://clinicaltrials.gov/study/NCT06118944","title":"Visual Outcomes of a New Monofocal Intraocular Lens With Modified Optical Profile: a Randomized Controlled Clinical Study","has_exemption":false,"start_date":"2019-11-11","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"University of Trieste","sponsor_slug":"university-of-trieste","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT04168944","publication_url":"https://clinicaltrials.gov/study/NCT04168944","title":"A Randomized Controlled Study of Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma","has_exemption":false,"start_date":"2019-11-30","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"RenJi Hospital","sponsor_slug":"renji-hospital","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT04158245","publication_url":"https://clinicaltrials.gov/study/NCT04158245","title":"Changes in 18F-fluciclovine Positron Emission Tomography (PET) in Patients With Metastatic Castration Resistant Prostate Cancer Treated With With Life Prolonging Therapies: A Pilot Study","has_exemption":false,"start_date":"2020-01-30","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Tulane University","sponsor_slug":"tulane-university","status":"reported-late","is_pact":false,"days_late":494},{"registry_id":"NCT03904264","publication_url":"https://clinicaltrials.gov/study/NCT03904264","title":"Feasibility and Acceptability of Using Low-Gain Hearing Aids for Bothersome Tinnitus","has_exemption":false,"start_date":"2020-02-24","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04273594","publication_url":"https://clinicaltrials.gov/study/NCT04273594","title":"BLOC: Prospective, Multi-Center, Study of Subjects Undergoing FemBloc Permanent Contraception With Two Confirmation Procedures (FemBloc With FemChec and Fluoro HSG)","has_exemption":false,"start_date":"2020-02-27","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Femasys Inc.","sponsor_slug":"femasys-inc","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT04220866","publication_url":"https://clinicaltrials.gov/study/NCT04220866","title":"A Phase 2 Study in First Line Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma to Evaluate Intratumoral MK-1454 in Combination With IV Pembrolizumab vs IV Pembrolizumab Monotherapy","has_exemption":false,"start_date":"2020-03-04","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04163419","publication_url":"https://clinicaltrials.gov/study/NCT04163419","title":"A Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Analgesic Efficacy and Safety of the Subcutaneous Administration of the Anti-NGF Antibody Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis","has_exemption":false,"start_date":"2020-04-30","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT04554407","publication_url":"https://clinicaltrials.gov/study/NCT04554407","title":"A Non-Randomized, Prospective Study to Evaluate the Performance of a Sustained Vacuum System","has_exemption":false,"start_date":"2020-08-11","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"SOMAVAC Medical Solutions","sponsor_slug":"somavac-medical-solutions","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT04553471","publication_url":"https://clinicaltrials.gov/study/NCT04553471","title":"A Trial of Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers","has_exemption":false,"start_date":"2020-09-22","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04725760","publication_url":"https://clinicaltrials.gov/study/NCT04725760","title":"Evaluation of the Efficacy of the BrainPort Vision Pro on the Performance of Daily Activities in the Profoundly Blind French Population","has_exemption":false,"start_date":"2020-10-01","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Wicab","sponsor_slug":"wicab","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT04216251","publication_url":"https://clinicaltrials.gov/study/NCT04216251","title":"PREPARE: PRevention Using EPA Against coloREctal Cancer","has_exemption":false,"start_date":"2020-12-09","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"reported-late","is_pact":false,"days_late":75},{"registry_id":"NCT04585243","publication_url":"https://clinicaltrials.gov/study/NCT04585243","title":"HPV Self-sampling Among Women at the Penn State Hershey Colposcopy Clinics","has_exemption":false,"start_date":"2020-12-09","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04682639","publication_url":"https://clinicaltrials.gov/study/NCT04682639","title":"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Etrasimod in Adult Subjects With Eosinophilic Esophagitis","has_exemption":false,"start_date":"2020-12-15","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05365022","publication_url":"https://clinicaltrials.gov/study/NCT05365022","title":"Clinical and Radiological Results in Robotic Assisted Knee Prosthetic Surgery With ROSA® Knee System.","has_exemption":false,"start_date":"2021-02-10","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Borja Alcobía-Díaz MD, PhD","sponsor_slug":"borja-alcobia-diaz-md-phd","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT04780685","publication_url":"https://clinicaltrials.gov/study/NCT04780685","title":"A Phase II, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients With Moderate to Severe ARDS Due to COVID-19","has_exemption":false,"start_date":"2021-03-20","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Stemedica Cell Technologies, Inc.","sponsor_slug":"stemedica-cell-technologies-inc","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT05114239","publication_url":"https://clinicaltrials.gov/study/NCT05114239","title":"Topical Timolol: a Comparison of Surgical Outcomes","has_exemption":false,"start_date":"2021-04-07","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Keith G. LeBlanc, Jr, MD","sponsor_slug":"keith-g-leblanc-jr-md","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT04790513","publication_url":"https://clinicaltrials.gov/study/NCT04790513","title":"Randomized, Open-label, Phase 3 Study to Evaluate the Efficacy and Safety of LIB003, Evolocumab and Alirocumab in CVD Patients, or at High Risk for CVD, on Stable Lipid-Lowering Therapy Requiring Additional LDL-C Reduction (LIBerate-H2H)","has_exemption":false,"start_date":"2021-04-22","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"LIB Therapeutics LLC","sponsor_slug":"lib-therapeutics-llc","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT04860713","publication_url":"https://clinicaltrials.gov/study/NCT04860713","title":"An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin and Nurtec (Rimegepant) in Adult Patients Presenting to the ED With Acute Headache: Prospective, Randomized, Open-Label, Clinical Trial","has_exemption":false,"start_date":"2021-04-22","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Antonios Likourezos","sponsor_slug":"antonios-likourezos","status":"reported-late","is_pact":false,"days_late":100},{"registry_id":"NCT03959566","publication_url":"https://clinicaltrials.gov/study/NCT03959566","title":"A Phase IIB, Open-Label, Randomized Controlled Dose Ranging Multi-Center Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Exposure-Response Relationship of Different Doses of Sutezolid in Combination With Bedaquiline, Delamanid and Moxifloxacin in Adult Subjects With Newly Diagnosed, Uncomplicated, Smear-Positive, Drug-sensitive Pulmonary Tuberculosis","has_exemption":false,"start_date":"2021-05-06","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Michael Hoelscher","sponsor_slug":"michael-hoelscher","status":"reported-late","is_pact":false,"days_late":719},{"registry_id":"NCT04876755","publication_url":"https://clinicaltrials.gov/study/NCT04876755","title":"An Open Label, Dose Comparison Study to Assess the Efficacy of MBM-02 (Tempol) as a Treatment for Patients Diagnosed With Prostate Cancer in Biochemical Recurrence","has_exemption":false,"start_date":"2021-05-30","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Matrix Biomed, Inc.","sponsor_slug":"matrix-biomed-inc","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT05048719","publication_url":"https://clinicaltrials.gov/study/NCT05048719","title":"A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo and Once-Weekly Dulaglutide in Participants With Type 2 Diabetes Mellitus","has_exemption":false,"start_date":"2021-09-15","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04395456","publication_url":"https://clinicaltrials.gov/study/NCT04395456","title":"A Phase 2 Clinical Trial to Assess the Safety and Efficacy of Complement 3 Inhibitor, AMY-101, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 (SAVE)","has_exemption":false,"start_date":"2021-09-30","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Amyndas Pharmaceuticals S.A.","sponsor_slug":"amyndas-pharmaceuticals-sa","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT04850313","publication_url":"https://clinicaltrials.gov/study/NCT04850313","title":"A Prospective, Randomized, Controlled Clinical Study to Evaluate the Use of ProKera Plus® in the Management of Bacterial Corneal Ulcers","has_exemption":false,"start_date":"2021-11-09","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05113212","publication_url":"https://clinicaltrials.gov/study/NCT05113212","title":"Randomized, Prospective, Descriptive and Comparative Clinical Study of Macular Grasping Damage in Patients Undergoing Pars Plana Vitrectomy and Peeling of the Internal Limiting Membrane, Operated by Traditional Microscope or NGENUITY® 3D Visualization System With Heads-up Display System. A Pilot Study.","has_exemption":false,"start_date":"2021-11-19","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Anna Rita Daniele, MD","sponsor_slug":"anna-rita-daniele-md","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT04979962","publication_url":"https://clinicaltrials.gov/study/NCT04979962","title":"Colorectal Polyp Detection Comparing Computer Assisted Colonoscopy With Conventional Colonoscopy","has_exemption":false,"start_date":"2021-11-24","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Fujifilm Medical Systems USA, Inc.","sponsor_slug":"fujifilm-medical-systems-usa-inc","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT05165290","publication_url":"https://clinicaltrials.gov/study/NCT05165290","title":"Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure","has_exemption":false,"start_date":"2021-11-29","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"TearClear Corp","sponsor_slug":"tearclear-corp","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT05157295","publication_url":"https://clinicaltrials.gov/study/NCT05157295","title":"Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial","has_exemption":false,"start_date":"2022-01-01","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Augusta University","sponsor_slug":"augusta-university","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT05069363","publication_url":"https://clinicaltrials.gov/study/NCT05069363","title":"Whole-Body Photobiomodulation Therapy for Chronic Pain: a Feasibility Trial","has_exemption":false,"start_date":"2022-01-12","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Sandwell & West Birmingham Hospitals NHS Trust","sponsor_slug":"sandwell-west-birmingham-hospitals-nhs-trust","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05207436","publication_url":"https://clinicaltrials.gov/study/NCT05207436","title":"Pilot Test of Intranasal Oxytocin as an Enhancer of Brief Couples Therapy for PTSD","has_exemption":false,"start_date":"2022-01-17","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"San Diego Veterans Healthcare System","sponsor_slug":"san-diego-veterans-healthcare-system","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05378477","publication_url":"https://clinicaltrials.gov/study/NCT05378477","title":"Randomized, Controlled, Assessor-Blinded, Comparative Study to Evaluate Safety & Efficacy of a New Suffocation Product vs an Oligodecene-based Suffocation Product, 1% Permethrin & a Fatty Acids-based Product in Subjects With Head Lice.","has_exemption":false,"start_date":"2022-01-17","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Oystershell NV","sponsor_slug":"oystershell-nv","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT05020990","publication_url":"https://clinicaltrials.gov/study/NCT05020990","title":"The Comparative Clinical Performance of Two Daily Disposable Toric Contact Lenses","has_exemption":false,"start_date":"2022-04-01","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Coopervision, Inc.","sponsor_slug":"coopervision-inc","status":"reported-late","is_pact":false,"days_late":59},{"registry_id":"NCT05384041","publication_url":"https://clinicaltrials.gov/study/NCT05384041","title":"Cranial Electrotherapy Stimulation for the Treatment of Major Depressive Disorder in Adults","has_exemption":false,"start_date":"2022-04-28","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Fisher Wallace Laboratories","sponsor_slug":"fisher-wallace-laboratories","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05258682","publication_url":"https://clinicaltrials.gov/study/NCT05258682","title":"Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease: a Phase 1 Study","has_exemption":false,"start_date":"2022-05-01","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Mucpharm Pty Ltd","sponsor_slug":"mucpharm-pty-ltd","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT05265065","publication_url":"https://clinicaltrials.gov/study/NCT05265065","title":"A Randomised Controlled Trial to Assess the Immunogenicity, Safety and Reactogenicity of Standard Dose Versus Fractional Doses of COVID-19 Vaccine (Pfizer-BioNTech) Given as a Booster Dose After Priming With Sinopharm, AstraZeneca or Sputnik in Healthy Adults in Mongolia","has_exemption":false,"start_date":"2022-05-27","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Murdoch Childrens Research Institute","sponsor_slug":"murdoch-childrens-research-institute","status":"reported-late","is_pact":false,"days_late":201},{"registry_id":"NCT05228834","publication_url":"https://clinicaltrials.gov/study/NCT05228834","title":"A Phase 3b, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Treatment Effect of Voxelotor on Neurocognitive Function in Pediatric Participants 8 to < 18 Years of Age With Sickle Cell Disease","has_exemption":false,"start_date":"2022-06-24","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported-late","is_pact":false,"days_late":191},{"registry_id":"NCT05427539","publication_url":"https://clinicaltrials.gov/study/NCT05427539","title":"Feasibility Evaluation of Daily Disposable Toric Soft Contact Lenses Manufactured With an Alternative Hydration Process","has_exemption":false,"start_date":"2022-07-12","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Johnson & Johnson Vision Care, Inc.","sponsor_slug":"johnson-johnson-vision-care-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05523349","publication_url":"https://clinicaltrials.gov/study/NCT05523349","title":"An Investigation on Function and Performance of a New Microprocessor-controlled Prosthetic Knee","has_exemption":false,"start_date":"2022-08-15","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Össur Iceland ehf","sponsor_slug":"ossur-iceland-ehf","status":"reported-late","is_pact":false,"days_late":752},{"registry_id":"NCT05505032","publication_url":"https://clinicaltrials.gov/study/NCT05505032","title":"Optimal FiO2 Value, Oxygen Reserve Index, and Prevention of Hyperoxemia in Children: A Prospective, Randomized, Single-blind Study","has_exemption":false,"start_date":"2022-08-17","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"Baskent University Ankara Hospital","sponsor_slug":"baskent-university-ankara-hospital","status":"overdue","is_pact":false,"days_late":1000},{"registry_id":"NCT05528237","publication_url":"https://clinicaltrials.gov/study/NCT05528237","title":"Advancing Cervical Cancer Screening Through Self-Sampling (ACCESS): A Pilot Study of HPV Self-sampling for Cervical Cancer Prevention in Washington State","has_exemption":false,"start_date":"2022-08-18","completion_date":"2022-09-30","has_results":false,"results_due":true,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"reported-late","is_pact":false,"days_late":236},{"registry_id":"NCT05633082","publication_url":"https://clinicaltrials.gov/study/NCT05633082","title":"A Clinical Performance of Two Soft Toric Contact Lenses","has_exemption":false,"start_date":"2022-09-21","completion_date":"2022-09-30","has_results":true,"results_due":true,"sponsor_name":"Coopervision, Inc.","sponsor_slug":"coopervision-inc","status":"reported-late","is_pact":false,"days_late":11},{"registry_id":"NCT02716038","publication_url":"https://clinicaltrials.gov/study/NCT02716038","title":"A Single-arm, Phase II Study of Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in Resectable Non-small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2016-06-07","completion_date":"2022-10-01","has_results":true,"results_due":true,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03556085","publication_url":"https://clinicaltrials.gov/study/NCT03556085","title":"Clinical Evaluation of the Serenity River Stent System to Treat Idiopathic Intracranial Hypertension","has_exemption":false,"start_date":"2018-08-24","completion_date":"2022-10-01","has_results":false,"results_due":true,"sponsor_name":"Serenity Medical, Inc.","sponsor_slug":"serenity-medical-inc","status":"overdue","is_pact":false,"days_late":999},{"registry_id":"NCT03502031","publication_url":"https://clinicaltrials.gov/study/NCT03502031","title":"Safety and Efficacy of Maximally Tolerated RAAS Blockade and Spironolactone Therapy on Urinary Proteinuria and Progression of Type II Diabetic Nephropathy in African Americans and Other Patient Cohorts.","has_exemption":false,"start_date":"2018-10-01","completion_date":"2022-10-01","has_results":false,"results_due":true,"sponsor_name":"James A. Tumlin, MD","sponsor_slug":"james-a-tumlin-md","status":"overdue","is_pact":false,"days_late":999},{"registry_id":"NCT03724019","publication_url":"https://clinicaltrials.gov/study/NCT03724019","title":"Evaluation of the Impact of the Use of Ketamine in Laparoscopic Surgery, Using the Quality of Recovery 15 Questionnaire.","has_exemption":false,"start_date":"2018-10-01","completion_date":"2022-10-01","has_results":false,"results_due":true,"sponsor_name":"Universidade do Porto","sponsor_slug":"universidade-do-porto","status":"overdue","is_pact":false,"days_late":999},{"registry_id":"NCT04093804","publication_url":"https://clinicaltrials.gov/study/NCT04093804","title":"Impact of Glenosphere Size on Range of Motion in Female Patients Undergoing Reverse Shoulder Arthroplasty","has_exemption":false,"start_date":"2019-10-01","completion_date":"2022-10-01","has_results":false,"results_due":true,"sponsor_name":"Fondren Orthopedic Group L.L.P.","sponsor_slug":"fondren-orthopedic-group-llp","status":"overdue","is_pact":false,"days_late":999},{"registry_id":"NCT04203056","publication_url":"https://clinicaltrials.gov/study/NCT04203056","title":"Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode","has_exemption":false,"start_date":"2019-12-16","completion_date":"2022-10-01","has_results":true,"results_due":true,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04335981","publication_url":"https://clinicaltrials.gov/study/NCT04335981","title":"A Randomized, Single-Center Study to Determine Swallow Outcomes in Subjects With Head and Neck Lymphedema Receiving Early Intervention With Pneumatic Compression","has_exemption":false,"start_date":"2020-09-24","completion_date":"2022-10-01","has_results":false,"results_due":true,"sponsor_name":"Tactile Medical","sponsor_slug":"tactile-medical","status":"overdue","is_pact":false,"days_late":999},{"registry_id":"NCT04697758","publication_url":"https://clinicaltrials.gov/study/NCT04697758","title":"Phase 1/2a Study of the Safety and Bioactivity of AXT-107 in Subjects With Diabetic Macular Edema (DME)","has_exemption":false,"start_date":"2020-12-10","completion_date":"2022-10-01","has_results":true,"results_due":true,"sponsor_name":"AsclepiX Therapeutics, Inc.","sponsor_slug":"asclepix-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":120},{"registry_id":"NCT04556084","publication_url":"https://clinicaltrials.gov/study/NCT04556084","title":"Blinatumomab Bridging Therapy in High-Risk B-Acute Lymphoblastic Leukemia: A Phase 2 Study","has_exemption":false,"start_date":"2021-01-01","completion_date":"2022-10-01","has_results":true,"results_due":true,"sponsor_name":"Michael Burke","sponsor_slug":"michael-burke","status":"reported-late","is_pact":false,"days_late":124},{"registry_id":"NCT04746963","publication_url":"https://clinicaltrials.gov/study/NCT04746963","title":"Phase 1/2a Study of the Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)","has_exemption":false,"start_date":"2021-02-01","completion_date":"2022-10-01","has_results":true,"results_due":true,"sponsor_name":"AsclepiX Therapeutics, Inc.","sponsor_slug":"asclepix-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":120},{"registry_id":"NCT04809220","publication_url":"https://clinicaltrials.gov/study/NCT04809220","title":"A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Two Doses of Dulaglutide in Combination With a Single Oral Antihyperglycemic Medication or as Monotherapy in Japanese Patients With Type 2 Diabetes Mellitus (AWARD-JPN: Assessment of Weekly Administration of LY2189265 in Diabetes - JAPAN)","has_exemption":false,"start_date":"2021-04-13","completion_date":"2022-10-01","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04761302","publication_url":"https://clinicaltrials.gov/study/NCT04761302","title":"Postoperative Pain Management in Patients Undergoing Intramedullary Nail Fixation After Tibia and Femoral Fractures","has_exemption":false,"start_date":"2021-04-18","completion_date":"2022-10-01","has_results":true,"results_due":true,"sponsor_name":"University of Puerto Rico","sponsor_slug":"university-of-puerto-rico","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04767334","publication_url":"https://clinicaltrials.gov/study/NCT04767334","title":"The Effect of Lower Body Positive Pressure Treadmill Training on Postural Control and Gait Function in Individuals With Chronic Stroke","has_exemption":false,"start_date":"2021-06-02","completion_date":"2022-10-01","has_results":false,"results_due":true,"sponsor_name":"Qassim University","sponsor_slug":"qassim-university","status":"overdue","is_pact":false,"days_late":999},{"registry_id":"NCT04540835","publication_url":"https://clinicaltrials.gov/study/NCT04540835","title":"Evaluation of the Effectiveness of Calcium-Phosphate-Containing Desensitizing Agent on Postoperative Sensitivity in Composite Restorations: A Double-Blind Prospective Randomized Controlled Study","has_exemption":false,"start_date":"2021-10-01","completion_date":"2022-10-01","has_results":true,"results_due":true,"sponsor_name":"Baskent University","sponsor_slug":"baskent-university","status":"reported-late","is_pact":false,"days_late":734},{"registry_id":"NCT04939584","publication_url":"https://clinicaltrials.gov/study/NCT04939584","title":"A Clinical Feasibility Study to Evaluate Patient Perception of MPT","has_exemption":false,"start_date":"2021-11-19","completion_date":"2022-10-01","has_results":false,"results_due":true,"sponsor_name":"Cardialen, Inc.","sponsor_slug":"cardialen-inc","status":"overdue","is_pact":false,"days_late":999},{"registry_id":"NCT05210192","publication_url":"https://clinicaltrials.gov/study/NCT05210192","title":"Sphenopalatine Ganglion Blockade With Local Analgesic in Episodic Migraine","has_exemption":false,"start_date":"2022-04-01","completion_date":"2022-10-01","has_results":false,"results_due":true,"sponsor_name":"Afyonkarahisar Health Sciences University","sponsor_slug":"afyonkarahisar-health-sciences-university","status":"overdue","is_pact":false,"days_late":999},{"registry_id":"NCT05337748","publication_url":"https://clinicaltrials.gov/study/NCT05337748","title":"Clinical Validation of the Lexie Lumen Over the Counter Hearing Aid","has_exemption":false,"start_date":"2022-04-11","completion_date":"2022-10-01","has_results":true,"results_due":true,"sponsor_name":"hearX Group","sponsor_slug":"hearx-group","status":"reported-late","is_pact":false,"days_late":150},{"registry_id":"NCT05302791","publication_url":"https://clinicaltrials.gov/study/NCT05302791","title":"Impact of Muscle Temperature on Muscle Growth and Breakdown: Cooling During Resistance Training","has_exemption":false,"start_date":"2022-04-19","completion_date":"2022-10-01","has_results":true,"results_due":true,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"reported-late","is_pact":false,"days_late":113},{"registry_id":"NCT05302804","publication_url":"https://clinicaltrials.gov/study/NCT05302804","title":"The Influence of Topical Menthol Gel on Thermoregulatory and Perceptual Outcomes During Exercise Within the Heat","has_exemption":false,"start_date":"2022-05-01","completion_date":"2022-10-01","has_results":true,"results_due":true,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"reported-late","is_pact":false,"days_late":73},{"registry_id":"NCT05298202","publication_url":"https://clinicaltrials.gov/study/NCT05298202","title":"The Influence of Topical Capsaicin on Thermoregulatory and Perceptual Outcomes During Exercise Within the Heat","has_exemption":false,"start_date":"2022-05-25","completion_date":"2022-10-01","has_results":true,"results_due":true,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"reported-late","is_pact":false,"days_late":114},{"registry_id":"NCT05529004","publication_url":"https://clinicaltrials.gov/study/NCT05529004","title":"Preoperative Pregabalin to Prevent Postoperative Nausea & Vomiting in Laparoscopic Surgery.","has_exemption":false,"start_date":"2022-09-30","completion_date":"2022-10-01","has_results":false,"results_due":true,"sponsor_name":"Al Safwa University College","sponsor_slug":"al-safwa-university-college","status":"overdue","is_pact":false,"days_late":999},{"registry_id":"NCT03871556","publication_url":"https://clinicaltrials.gov/study/NCT03871556","title":"Diagnostic Ultrasound for Measuring Fat of the Body","has_exemption":false,"start_date":"2019-03-20","completion_date":"2022-10-02","has_results":true,"results_due":true,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04689828","publication_url":"https://clinicaltrials.gov/study/NCT04689828","title":"PSMAfore: A Phase III, Open-label, Multi-Center, Randomized Study Comparing 177Lu-PSMA-617 vs. a Change of Androgen Receptor-Directed Therapy in the Treatment of Taxane Naïve Men With Progressive Metastatic Castrate Resistant Prostate Cancer","has_exemption":true,"start_date":"2021-06-15","completion_date":"2022-10-02","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03395197","publication_url":"https://clinicaltrials.gov/study/NCT03395197","title":"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER","has_exemption":false,"start_date":"2017-12-18","completion_date":"2022-10-03","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03349476","publication_url":"https://clinicaltrials.gov/study/NCT03349476","title":"Left Atrial Anatomy Reconstruction Using Model Based Fast Anatomical Mapping","has_exemption":false,"start_date":"2018-04-16","completion_date":"2022-10-03","has_results":true,"results_due":true,"sponsor_name":"Vivek Reddy","sponsor_slug":"vivek-reddy","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03535727","publication_url":"https://clinicaltrials.gov/study/NCT03535727","title":"A Phase I/II Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan (GAX-CI) in Combination in Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2018-06-21","completion_date":"2022-10-03","has_results":true,"results_due":true,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03635567","publication_url":"https://clinicaltrials.gov/study/NCT03635567","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Chemotherapy Plus Placebo for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer (KEYNOTE-826)","has_exemption":false,"start_date":"2018-10-25","completion_date":"2022-10-03","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03675737","publication_url":"https://clinicaltrials.gov/study/NCT03675737","title":"A Phase 3, Randomized, Double-blind Clinical Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy as First-line Treatment in Participants With HER2 Negative, Previously Untreated, Unresectable or Metastatic Gastric Orgastroesophageal Junction Adenocarcinoma (KEYNOTE-859)","has_exemption":false,"start_date":"2018-11-08","completion_date":"2022-10-03","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03913130","publication_url":"https://clinicaltrials.gov/study/NCT03913130","title":"An Open-Label, Extension Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene","has_exemption":false,"start_date":"2019-05-13","completion_date":"2022-10-03","has_results":true,"results_due":true,"sponsor_name":"Laboratoires Thea","sponsor_slug":"laboratoires-thea","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04132596","publication_url":"https://clinicaltrials.gov/study/NCT04132596","title":"Non-invasive Spinal Cord Stimulation Combined With Activity-based Rehabilitation in Chronic Spinal Cord Injury","has_exemption":false,"start_date":"2019-11-11","completion_date":"2022-10-03","has_results":false,"results_due":true,"sponsor_name":"The Neurokinex Charitable Trust","sponsor_slug":"the-neurokinex-charitable-trust","status":"overdue","is_pact":false,"days_late":997},{"registry_id":"NCT04135495","publication_url":"https://clinicaltrials.gov/study/NCT04135495","title":"A Phase 2 Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dose Levels of Subcutaneously Administered ELX-02 in Patients With Cystic Fibrosis With at Least One G542X Allele","has_exemption":false,"start_date":"2019-11-25","completion_date":"2022-10-03","has_results":false,"results_due":true,"sponsor_name":"Eloxx Pharmaceuticals, Inc.","sponsor_slug":"eloxx-pharmaceuticals-inc","status":"overdue","is_pact":false,"days_late":997},{"registry_id":"NCT04364035","publication_url":"https://clinicaltrials.gov/study/NCT04364035","title":"A Phase IIa Randomised, Double-blind, Placebo-controlled Study of HIV-1 Vaccines MVA.HTI and ChAdOx1.HTI With TLR7 Agonist Vesatolimod (GS-9620) in Early Treated HIV-1 Infection","has_exemption":false,"start_date":"2020-02-20","completion_date":"2022-10-03","has_results":false,"results_due":true,"sponsor_name":"Aelix Therapeutics","sponsor_slug":"aelix-therapeutics","status":"overdue","is_pact":false,"days_late":997},{"registry_id":"NCT04220775","publication_url":"https://clinicaltrials.gov/study/NCT04220775","title":"Phase I/II Study of M7824 Plus Curative Intent Re-Irradiation With Stereotactic Body Radiation Therapy (SBRT) in Patients With Local-Regionally Recurrent Head and Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2020-03-18","completion_date":"2022-10-03","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04503551","publication_url":"https://clinicaltrials.gov/study/NCT04503551","title":"A Phase III, Multicenter, Randomized Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Patients With Diabetic Retinopathy","has_exemption":true,"start_date":"2020-08-10","completion_date":"2022-10-03","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04367480","publication_url":"https://clinicaltrials.gov/study/NCT04367480","title":"Wireless Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy-Induced Peripheral Neuropathy: A Phase II Clinical Trial","has_exemption":false,"start_date":"2020-09-10","completion_date":"2022-10-03","has_results":true,"results_due":true,"sponsor_name":"University of Rochester NCORP Research Base","sponsor_slug":"university-of-rochester-ncorp-research-base","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04544475","publication_url":"https://clinicaltrials.gov/study/NCT04544475","title":"A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause","has_exemption":false,"start_date":"2021-09-01","completion_date":"2022-10-03","has_results":true,"results_due":true,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04210609","publication_url":"https://clinicaltrials.gov/study/NCT04210609","title":"Treating Non-healing Foot Wounds With Vaporous Hyperoxia Therapy as an Adjunct to Standard Wound Care","has_exemption":false,"start_date":"2021-10-04","completion_date":"2022-10-03","has_results":false,"results_due":true,"sponsor_name":"Vaporox","sponsor_slug":"vaporox","status":"overdue","is_pact":false,"days_late":997},{"registry_id":"NCT07190352","publication_url":"https://clinicaltrials.gov/study/NCT07190352","title":"Behavioral Impact and Neural Correlates of Network-based Brain Stimulation in Schizophrenia","has_exemption":false,"start_date":"2021-10-04","completion_date":"2022-10-03","has_results":false,"results_due":true,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"reported-late","is_pact":false,"days_late":929},{"registry_id":"NCT05612763","publication_url":"https://clinicaltrials.gov/study/NCT05612763","title":"Self Fitting Hearing Aid Clinical Investigation","has_exemption":false,"start_date":"2022-08-18","completion_date":"2022-10-03","has_results":false,"results_due":true,"sponsor_name":"Starkey Laboratories, Inc","sponsor_slug":"starkey-laboratories-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04045613","publication_url":"https://clinicaltrials.gov/study/NCT04045613","title":"An Open-label Multi-cohort Phase 1b/2 Study of Derazantinib and Atezolizumab in Patients With Urothelial Cancer Expressing Activating Molecular FGFR Aberrations","has_exemption":false,"start_date":"2019-08-02","completion_date":"2022-10-04","has_results":true,"results_due":true,"sponsor_name":"Basilea Pharmaceutica","sponsor_slug":"basilea-pharmaceutica","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04386746","publication_url":"https://clinicaltrials.gov/study/NCT04386746","title":"A Phase II Trial for the Use of Intravesical Gemcitabine and Docetaxel (GEMDOCE) in the Treatment of BCG naïve Non-muscle Invasive Urothelial Carcinoma of the Bladder","has_exemption":false,"start_date":"2020-07-29","completion_date":"2022-10-04","has_results":true,"results_due":true,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04542278","publication_url":"https://clinicaltrials.gov/study/NCT04542278","title":"Randomized Controlled Trial of Preoperative Steroids in Autoimmune Thyroid Disease","has_exemption":false,"start_date":"2020-11-13","completion_date":"2022-10-04","has_results":true,"results_due":true,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04936841","publication_url":"https://clinicaltrials.gov/study/NCT04936841","title":"Phase II Study of Bempegaldesleukin (NKTR-214) Together With Palliative Radiation and Anti-PD-1 Checkpoint Blockade in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)","has_exemption":false,"start_date":"2021-08-05","completion_date":"2022-10-04","has_results":true,"results_due":true,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"reported-late","is_pact":false,"days_late":127},{"registry_id":"NCT04182490","publication_url":"https://clinicaltrials.gov/study/NCT04182490","title":"A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Single Dose Regimen Study of LMN-101 in Healthy Volunteers Challenged With Campylobacter Jejuni","has_exemption":false,"start_date":"2022-02-21","completion_date":"2022-10-04","has_results":true,"results_due":true,"sponsor_name":"Lumen Bioscience, Inc.","sponsor_slug":"lumen-bioscience-inc","status":"reported-late","is_pact":false,"days_late":545},{"registry_id":"NCT05219604","publication_url":"https://clinicaltrials.gov/study/NCT05219604","title":"The Magnitude and Duration of the Central Nervous System Effects Following Intravenous Infusion of Diphenhydramine Using Pharmacokinetic and Pharmacodynamic Modeling","has_exemption":false,"start_date":"2022-03-15","completion_date":"2022-10-04","has_results":true,"results_due":true,"sponsor_name":"Dent Neuroscience Research Center","sponsor_slug":"dent-neuroscience-research-center","status":"reported-late","is_pact":false,"days_late":754},{"registry_id":"NCT02839265","publication_url":"https://clinicaltrials.gov/study/NCT02839265","title":"FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2016-07-31","completion_date":"2022-10-05","has_results":true,"results_due":true,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"reported-late","is_pact":true,"days_late":167},{"registry_id":"NCT04282148","publication_url":"https://clinicaltrials.gov/study/NCT04282148","title":"A Clinical Investigation to Assess the Abbott Next Generation Drug Eluting Stent 48mm Everolimus Eluting Coronary Stent System (EECSS) in Treatment of de Novo Native Coronary Artery Disease","has_exemption":false,"start_date":"2020-06-17","completion_date":"2022-10-05","has_results":true,"results_due":true,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"reported-late","is_pact":false,"days_late":103},{"registry_id":"NCT04492566","publication_url":"https://clinicaltrials.gov/study/NCT04492566","title":"Supervised Safety and Feasibility Evaluation of the Zone-MPC Control Algorithm Integrated Into the iAPS in Pregnant Patients With Type 1 Diabetes With Extension Into Outpatient at Home","has_exemption":false,"start_date":"2020-07-27","completion_date":"2022-10-05","has_results":true,"results_due":true,"sponsor_name":"Sansum Diabetes Research Institute","sponsor_slug":"sansum-diabetes-research-institute","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04389866","publication_url":"https://clinicaltrials.gov/study/NCT04389866","title":"Jowl Improvement With Injectable Fillers: Jawline Injections Alone vs Jawline and Cheek Injections","has_exemption":false,"start_date":"2020-09-25","completion_date":"2022-10-05","has_results":true,"results_due":true,"sponsor_name":"Advanced Dermatology","sponsor_slug":"advanced-dermatology","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04715230","publication_url":"https://clinicaltrials.gov/study/NCT04715230","title":"Meth-OD: A Phase 2a Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose","has_exemption":false,"start_date":"2021-06-30","completion_date":"2022-10-05","has_results":true,"results_due":true,"sponsor_name":"InterveXion Therapeutics, LLC","sponsor_slug":"intervexion-therapeutics-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03634488","publication_url":"https://clinicaltrials.gov/study/NCT03634488","title":"Management of Severe Acute Malnutrition in Children With Sickle Cell Disease Greater Than 5 Years of Age Living in Northern Nigeria","has_exemption":false,"start_date":"2021-08-18","completion_date":"2022-10-05","has_results":true,"results_due":true,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"reported-late","is_pact":false,"days_late":1},{"registry_id":"NCT05310084","publication_url":"https://clinicaltrials.gov/study/NCT05310084","title":"A PHASE 3, RANDOMIZED, OBSERVER-BLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF BNT162b2 WHEN COADMINISTERED WITH SEASONAL INACTIVATED INFLUENZA VACCINE (SIIV) IN ADULTS 18 THROUGH 64 YEARS OF AGE","has_exemption":false,"start_date":"2022-04-20","completion_date":"2022-10-05","has_results":true,"results_due":true,"sponsor_name":"Biontech SE","sponsor_slug":"biontech-se","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05542849","publication_url":"https://clinicaltrials.gov/study/NCT05542849","title":"The Efficacy and Tolerability of Acarbose in Healthy Individuals: A Prospective Trial for Acarbose in Healthy Individuals Assessing Safety and Efficacy in Reducing Glucose Spikes After Carbohydrate Consumption.","has_exemption":false,"start_date":"2022-08-10","completion_date":"2022-10-05","has_results":false,"results_due":true,"sponsor_name":"AgelessRx","sponsor_slug":"agelessrx","status":"reported-late","is_pact":false,"days_late":545},{"registry_id":"NCT02074631","publication_url":"https://clinicaltrials.gov/study/NCT02074631","title":"Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation","has_exemption":true,"start_date":"2015-02-28","completion_date":"2022-10-06","has_results":true,"results_due":true,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02782949","publication_url":"https://clinicaltrials.gov/study/NCT02782949","title":"Randomized, Double-Blind, Placebo-Controlled Trial of Meriva® (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis","has_exemption":false,"start_date":"2017-04-04","completion_date":"2022-10-06","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":false,"days_late":46},{"registry_id":"NCT03613727","publication_url":"https://clinicaltrials.gov/study/NCT03613727","title":"Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients","has_exemption":false,"start_date":"2018-10-01","completion_date":"2022-10-06","has_results":true,"results_due":true,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03719313","publication_url":"https://clinicaltrials.gov/study/NCT03719313","title":"A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID With and Without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared With PEG IFN-alfa-2a Monotherapy and Placebo Treatment in Patients Chronically Infected With Hepatitis Delta Virus Being Maintained on Anti-HBV Nucleos(t)Ide Therapy (D-LIVR)","has_exemption":false,"start_date":"2018-12-01","completion_date":"2022-10-06","has_results":false,"results_due":true,"sponsor_name":"Eiger BioPharmaceuticals","sponsor_slug":"eiger-biopharmaceuticals","status":"overdue","is_pact":false,"days_late":994},{"registry_id":"NCT05008835","publication_url":"https://clinicaltrials.gov/study/NCT05008835","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee","has_exemption":false,"start_date":"2021-07-20","completion_date":"2022-10-06","has_results":true,"results_due":true,"sponsor_name":"ACADIA Pharmaceuticals Inc.","sponsor_slug":"acadia-pharmaceuticals-inc","status":"reported-late","is_pact":false,"days_late":431},{"registry_id":"NCT05011890","publication_url":"https://clinicaltrials.gov/study/NCT05011890","title":"Feasibility and Acceptability of Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®","has_exemption":false,"start_date":"2021-09-01","completion_date":"2022-10-06","has_results":true,"results_due":true,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04203199","publication_url":"https://clinicaltrials.gov/study/NCT04203199","title":"H-coil TMS to Reduce Pain: A Pilot Study Evaluating Relative Efficacy of the H1 vs H7 Coil","has_exemption":false,"start_date":"2022-01-18","completion_date":"2022-10-06","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05098509","publication_url":"https://clinicaltrials.gov/study/NCT05098509","title":"A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of RAD011 (Cannabidiol Oral Solution) for the Treatment of Patients With Prader- Willi Syndrome","has_exemption":false,"start_date":"2022-04-13","completion_date":"2022-10-06","has_results":true,"results_due":true,"sponsor_name":"Radius Pharmaceuticals, Inc.","sponsor_slug":"radius-pharmaceuticals-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04892355","publication_url":"https://clinicaltrials.gov/study/NCT04892355","title":"Postoperative Pain After İntracanal Procedures Based On Different İrrigation Activation Tecniques: A Randomized, Clinical Trial","has_exemption":false,"start_date":"2022-08-06","completion_date":"2022-10-06","has_results":false,"results_due":true,"sponsor_name":"Afyonkarahisar Health Sciences University","sponsor_slug":"afyonkarahisar-health-sciences-university","status":"overdue","is_pact":false,"days_late":994},{"registry_id":"NCT04886479","publication_url":"https://clinicaltrials.gov/study/NCT04886479","title":"Comparing Habitual Daily Disposable Silicone Hydrogel (DDSH) Contact Lens Wearers to Habitual Daily Disposable Hydrogel (DDH) Contact Lens Wearers and Non-lens Wearers","has_exemption":false,"start_date":"2019-03-06","completion_date":"2022-10-07","has_results":true,"results_due":true,"sponsor_name":"Coopervision, Inc.","sponsor_slug":"coopervision-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03877055","publication_url":"https://clinicaltrials.gov/study/NCT03877055","title":"Phase I/II Clinical Trial of Copanlisib and Ibrutinib in Mantle Cell Lymphoma","has_exemption":false,"start_date":"2019-03-13","completion_date":"2022-10-07","has_results":true,"results_due":true,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04534842","publication_url":"https://clinicaltrials.gov/study/NCT04534842","title":"An Open-label Study of the Efficacy and Safety of SYNB1618 and SYNB1934 in Patients With Phenylketonuria (SynPheny-1)","has_exemption":false,"start_date":"2020-08-25","completion_date":"2022-10-07","has_results":false,"results_due":true,"sponsor_name":"Synlogic","sponsor_slug":"synlogic","status":"overdue","is_pact":false,"days_late":993},{"registry_id":"NCT04433767","publication_url":"https://clinicaltrials.gov/study/NCT04433767","title":"Nicotinic Modulation of the Cognitive Control System in Late-life Depression","has_exemption":false,"start_date":"2020-12-15","completion_date":"2022-10-07","has_results":true,"results_due":true,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04145635","publication_url":"https://clinicaltrials.gov/study/NCT04145635","title":"An Evaluation of the Safety and Performance of the Aortix System for Intra-Aortic Mechanical Circulatory Support in Patients With Cardiorenal Syndrome","has_exemption":false,"start_date":"2021-02-05","completion_date":"2022-10-07","has_results":true,"results_due":true,"sponsor_name":"Procyrion","sponsor_slug":"procyrion","status":"reported-late","is_pact":false,"days_late":13},{"registry_id":"NCT04792970","publication_url":"https://clinicaltrials.gov/study/NCT04792970","title":"Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion - The ASAP II Trial","has_exemption":false,"start_date":"2021-03-18","completion_date":"2022-10-07","has_results":true,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04288115","publication_url":"https://clinicaltrials.gov/study/NCT04288115","title":"Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism: a Pilot Randomized, Double-blinded, Placebo-controlled Study","has_exemption":false,"start_date":"2021-03-24","completion_date":"2022-10-07","has_results":true,"results_due":true,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05033743","publication_url":"https://clinicaltrials.gov/study/NCT05033743","title":"Suppressive Antibacterial Therapy With Once-Weekly Secnidazole Granules to Prevent Recurrent Bacterial Vaginosis; A Pilot Study","has_exemption":false,"start_date":"2021-07-09","completion_date":"2022-10-07","has_results":true,"results_due":true,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"reported-late","is_pact":false,"days_late":16},{"registry_id":"NCT05496062","publication_url":"https://clinicaltrials.gov/study/NCT05496062","title":"Evaluation of the Toffee Nasal and Toffee Nasal Pillows Mask in Home, USA, 2022","has_exemption":false,"start_date":"2022-09-12","completion_date":"2022-10-07","has_results":false,"results_due":true,"sponsor_name":"Fisher and Paykel Healthcare","sponsor_slug":"fisher-and-paykel-healthcare","status":"reported-late","is_pact":false,"days_late":599},{"registry_id":"NCT05252858","publication_url":"https://clinicaltrials.gov/study/NCT05252858","title":"A Pilot Study Investigating the nCAP Signal Relief Patch in Subjects Undergoing Primary Hip or Knee Replacement Surgery: A Prospective, Randomized, Open Label Trial","has_exemption":false,"start_date":"2022-03-21","completion_date":"2022-10-08","has_results":true,"results_due":true,"sponsor_name":"Jacques E. Chelly","sponsor_slug":"jacques-e-chelly","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05193643","publication_url":"https://clinicaltrials.gov/study/NCT05193643","title":"Minimally Invasive Treatment of Primary Great Saphenous Vein (GSV) Insufficiency Using High Intensity Focused Ultrasound (HIFU) Generated by Sonovein: A Single Center Prospective Feasibility Study","has_exemption":false,"start_date":"2022-03-23","completion_date":"2022-10-08","has_results":false,"results_due":true,"sponsor_name":"Englewood Hospital and Medical Center","sponsor_slug":"englewood-hospital-and-medical-center","status":"reported-late","is_pact":false,"days_late":908},{"registry_id":"NCT01996605","publication_url":"https://clinicaltrials.gov/study/NCT01996605","title":"Efficacy of Intrathecal Oxytocin in Human Volunteers","has_exemption":false,"start_date":"2014-01-02","completion_date":"2022-10-10","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02100956","publication_url":"https://clinicaltrials.gov/study/NCT02100956","title":"Efficacy of Intrathecal Oxytocin in Patients With Neuropathic Pain","has_exemption":false,"start_date":"2014-06-19","completion_date":"2022-10-10","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT04068610","publication_url":"https://clinicaltrials.gov/study/NCT04068610","title":"A Phase Ib/II, Open-label, Multicenter Study of Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First-line Therapy in Metastatic Microsatellite-stable Colorectal Cancer (COLUMBIA-1)","has_exemption":false,"start_date":"2019-09-13","completion_date":"2022-10-10","has_results":true,"results_due":true,"sponsor_name":"MedImmune LLC","sponsor_slug":"medimmune-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06552026","publication_url":"https://clinicaltrials.gov/study/NCT06552026","title":"Intermittent Theta Burst Stimulation on Anhedonia of Treatment Resistant Depression and Brian Network Mechanism","has_exemption":false,"start_date":"2020-08-12","completion_date":"2022-10-10","has_results":false,"results_due":true,"sponsor_name":"Anhui Medical University","sponsor_slug":"anhui-medical-university","status":"overdue","is_pact":false,"days_late":990},{"registry_id":"NCT05079672","publication_url":"https://clinicaltrials.gov/study/NCT05079672","title":"Efficacy and Safety of Dexmedetomidine in the Analgesic Prophylaxis , in Patients Undergoing Cardiovascular Surgery: Randomized Clinical Trial","has_exemption":false,"start_date":"2021-10-07","completion_date":"2022-10-10","has_results":false,"results_due":true,"sponsor_name":"University of Sao Paulo","sponsor_slug":"university-of-sao-paulo","status":"overdue","is_pact":false,"days_late":990},{"registry_id":"NCT05004077","publication_url":"https://clinicaltrials.gov/study/NCT05004077","title":"Repeated Amiodarone Dosing In Cardiac surgicaL Procedures","has_exemption":false,"start_date":"2021-11-02","completion_date":"2022-10-10","has_results":true,"results_due":true,"sponsor_name":"Kevin W Hatton, MD, PhD","sponsor_slug":"kevin-w-hatton-md-phd","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05193409","publication_url":"https://clinicaltrials.gov/study/NCT05193409","title":"A Phase 2, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of BNC210 Compared to Placebo for the Acute Treatment of Social Anxiety Disorder","has_exemption":false,"start_date":"2022-02-02","completion_date":"2022-10-10","has_results":true,"results_due":true,"sponsor_name":"Bionomics Limited","sponsor_slug":"bionomics-limited","status":"reported-late","is_pact":false,"days_late":495},{"registry_id":"NCT03158805","publication_url":"https://clinicaltrials.gov/study/NCT03158805","title":"A Randomized, Placebo-Controlled Study of Liraglutide 3mg Daily (Saxenda®) in Obese or Overweight Patients With Stable Bipolar Disorder","has_exemption":false,"start_date":"2017-04-26","completion_date":"2022-10-11","has_results":true,"results_due":true,"sponsor_name":"Lindner Center of HOPE","sponsor_slug":"lindner-center-of-hope","status":"reported-late","is_pact":false,"days_late":70},{"registry_id":"NCT04569799","publication_url":"https://clinicaltrials.gov/study/NCT04569799","title":"Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma (HCC) Post Transcatheter Arterial Chemoembolization (TACE)","has_exemption":false,"start_date":"2020-10-14","completion_date":"2022-10-11","has_results":true,"results_due":true,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04537923","publication_url":"https://clinicaltrials.gov/study/NCT04537923","title":"A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)","has_exemption":false,"start_date":"2020-10-19","completion_date":"2022-10-11","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04735393","publication_url":"https://clinicaltrials.gov/study/NCT04735393","title":"A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of 0.25% Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease","has_exemption":true,"start_date":"2021-01-26","completion_date":"2022-10-11","has_results":true,"results_due":true,"sponsor_name":"Aldeyra Therapeutics, Inc.","sponsor_slug":"aldeyra-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":6},{"registry_id":"NCT05063877","publication_url":"https://clinicaltrials.gov/study/NCT05063877","title":"A Dose-Ranging Safety, Tolerability, and Exploratory Efficacy Study of Adjunctive EQU-001 for Seizures in Adults With Epilepsy","has_exemption":false,"start_date":"2021-08-31","completion_date":"2022-10-11","has_results":false,"results_due":true,"sponsor_name":"Equilibre Biopharmaceuticals B.V.","sponsor_slug":"equilibre-biopharmaceuticals-bv","status":"overdue","is_pact":false,"days_late":989},{"registry_id":"NCT02341807","publication_url":"https://clinicaltrials.gov/study/NCT02341807","title":"A Phase 1/2 Safety Study in Subjects With CHM (Choroideremia) Gene Mutations Using an Adeno-Associated Virus Serotype 2 Vector to Deliver the Normal Human CHM Gene [AAV2-hCHM] to the Retina","has_exemption":false,"start_date":"2015-01-15","completion_date":"2022-10-12","has_results":true,"results_due":true,"sponsor_name":"Spark Therapeutics, Inc.","sponsor_slug":"spark-therapeutics-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02500576","publication_url":"https://clinicaltrials.gov/study/NCT02500576","title":"Phase II Study of MK-3475 in Conjunction With Lymphodepletion, TIL, and High or Low Dose IL-2 in Patients With Metastatic Melanoma","has_exemption":false,"start_date":"2015-08-07","completion_date":"2022-10-12","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02290119","publication_url":"https://clinicaltrials.gov/study/NCT02290119","title":"PILOT STUDY: Gait and Functional Improvement in Total Knee Arthroplasty With the Use of Verasense for Soft Tissue Balancing: A Randomized, Double-Blind, Controlled Trial","has_exemption":false,"start_date":"2018-04-01","completion_date":"2022-10-12","has_results":false,"results_due":true,"sponsor_name":"Orthosensor, Inc.","sponsor_slug":"orthosensor-inc","status":"reported-late","is_pact":false,"days_late":977},{"registry_id":"NCT03434418","publication_url":"https://clinicaltrials.gov/study/NCT03434418","title":"A Single Arm Phase II Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations","has_exemption":false,"start_date":"2018-06-30","completion_date":"2022-10-12","has_results":true,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03915574","publication_url":"https://clinicaltrials.gov/study/NCT03915574","title":"Dural Puncture Epidural Versus Epidural Anesthesia for Cesarean Delivery: A Randomized, Double-blind Study","has_exemption":false,"start_date":"2019-05-09","completion_date":"2022-10-12","has_results":true,"results_due":true,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03753789","publication_url":"https://clinicaltrials.gov/study/NCT03753789","title":"A Multicenter Study to Evaluate NEUWAVE Microwave Ablation System Using Ablation Confirmation in Patients With a Soft Tissue Liver Lesion","has_exemption":false,"start_date":"2019-11-05","completion_date":"2022-10-12","has_results":true,"results_due":true,"sponsor_name":"Ethicon, Inc.","sponsor_slug":"ethicon-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05993299","publication_url":"https://clinicaltrials.gov/study/NCT05993299","title":"Evaluation of Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma","has_exemption":false,"start_date":"2019-12-31","completion_date":"2022-10-12","has_results":true,"results_due":true,"sponsor_name":"USWM, LLC (dba US WorldMeds)","sponsor_slug":"uswm-llc-dba-us-worldmeds","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04734210","publication_url":"https://clinicaltrials.gov/study/NCT04734210","title":"A Multicenter, Randomized, Double-Masked, Dose-Ranging Study To Compare The Ocular Safety, Tolerability, And Efficacy Of SURF-200 Ophthalmic Solution (0.02% And 0.04% Betamethasone Sodium Phosphate) To Vehicle In Subjects With A Diagnosis Of Dry Eye Disease And Experiencing An Episodic Flare Up","has_exemption":true,"start_date":"2021-01-07","completion_date":"2022-10-12","has_results":true,"results_due":true,"sponsor_name":"Surface Ophthalmics, Inc.","sponsor_slug":"surface-ophthalmics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04810481","publication_url":"https://clinicaltrials.gov/study/NCT04810481","title":"Bispectral Index and End-Tidal Anesthetic Gas Concentration in Pediatric Patients Undergoing Sevoflurane Anesthesia (BTIGER)","has_exemption":false,"start_date":"2021-07-02","completion_date":"2022-10-12","has_results":true,"results_due":true,"sponsor_name":"Medtronic - MITG","sponsor_slug":"medtronic-mitg","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04647890","publication_url":"https://clinicaltrials.gov/study/NCT04647890","title":"A Phase II, Randomised, Double Blind, Placebo-controlled Study of the Pharmacokinetics, Pharmacodynamic Effects, and Safety, of Oral FT011 in Participants With Diffuse Systemic Sclerosis","has_exemption":false,"start_date":"2021-07-19","completion_date":"2022-10-12","has_results":true,"results_due":true,"sponsor_name":"Certa Therapeutics","sponsor_slug":"certa-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05158296","publication_url":"https://clinicaltrials.gov/study/NCT05158296","title":"A Double-Masked, Randomized, Controlled, Multiple-Dose Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene (Sirius)","has_exemption":false,"start_date":"2021-12-08","completion_date":"2022-10-12","has_results":true,"results_due":true,"sponsor_name":"Laboratoires Thea","sponsor_slug":"laboratoires-thea","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04582669","publication_url":"https://clinicaltrials.gov/study/NCT04582669","title":"Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa","has_exemption":false,"start_date":"2022-01-24","completion_date":"2022-10-12","has_results":true,"results_due":true,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05301322","publication_url":"https://clinicaltrials.gov/study/NCT05301322","title":"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE WHEN COADMINISTERED WITH SEASONAL INACTIVATED INFLUENZA VACCINE IN ADULTS ≥65 YEARS OF AGE","has_exemption":false,"start_date":"2022-04-13","completion_date":"2022-10-12","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05516082","publication_url":"https://clinicaltrials.gov/study/NCT05516082","title":"Clinical Evaluation of Two Daily Disposable Lenses in Sphere Design","has_exemption":false,"start_date":"2022-08-08","completion_date":"2022-10-12","has_results":true,"results_due":true,"sponsor_name":"Coopervision, Inc.","sponsor_slug":"coopervision-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02040142","publication_url":"https://clinicaltrials.gov/study/NCT02040142","title":"Phase II Trial of Cytoreduction + Hyperthermic Intraperitoneal Mitomycin-C+ Standard Systemic Therapy In Patients With Peritoneal Carcinomatosis","has_exemption":false,"start_date":"2011-11-30","completion_date":"2022-10-13","has_results":true,"results_due":true,"sponsor_name":"Albert Einstein College of Medicine","sponsor_slug":"albert-einstein-college-of-medicine","status":"reported-late","is_pact":true,"days_late":347},{"registry_id":"NCT03439514","publication_url":"https://clinicaltrials.gov/study/NCT03439514","title":"A Phase 3, Multinational, Randomized, Placebo-controlled Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation (REALM-DCM)","has_exemption":false,"start_date":"2018-04-17","completion_date":"2022-10-13","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported-late","is_pact":false,"days_late":66},{"registry_id":"NCT03422627","publication_url":"https://clinicaltrials.gov/study/NCT03422627","title":"A Phase 1b/2 Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Efavaleukin Alfa in Adult Subjects With Steroid Refractory Chronic Graft Versus Host Disease","has_exemption":false,"start_date":"2018-04-27","completion_date":"2022-10-13","has_results":true,"results_due":true,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"reported-late","is_pact":false,"days_late":20},{"registry_id":"NCT03496623","publication_url":"https://clinicaltrials.gov/study/NCT03496623","title":"A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)","has_exemption":false,"start_date":"2018-05-08","completion_date":"2022-10-13","has_results":true,"results_due":true,"sponsor_name":"United Therapeutics","sponsor_slug":"united-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03647774","publication_url":"https://clinicaltrials.gov/study/NCT03647774","title":"Long Acting Naltrexone for Opioid Addiction: the Importance of Mental, Physical and Societal Factors for Sustained Abstinence and Recovery","has_exemption":false,"start_date":"2018-08-01","completion_date":"2022-10-13","has_results":false,"results_due":true,"sponsor_name":"Lars Tanum","sponsor_slug":"lars-tanum","status":"overdue","is_pact":false,"days_late":987},{"registry_id":"NCT03691493","publication_url":"https://clinicaltrials.gov/study/NCT03691493","title":"A Phase II Multi-Institutional Study of Concurrent Radiotherapy, Palbociclib, and Hormone Therapy for Treatment of Bone Metastasis in Breast Cancer Patients","has_exemption":true,"start_date":"2019-02-08","completion_date":"2022-10-13","has_results":true,"results_due":true,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04218071","publication_url":"https://clinicaltrials.gov/study/NCT04218071","title":"Phase 2 Study of 9-ING-41, a Glycogen Synthase Kinase 3 Beta (GSK 3β) Inhibitor, as a Single Agent or Combined With Ruxolitinib, in Patients With Myelofibrosis","has_exemption":false,"start_date":"2020-08-20","completion_date":"2022-10-13","has_results":false,"results_due":true,"sponsor_name":"Actuate Therapeutics Inc.","sponsor_slug":"actuate-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":462},{"registry_id":"NCT04612725","publication_url":"https://clinicaltrials.gov/study/NCT04612725","title":"A Phase 2b Multinational, Randomised, Double-blind, Parallel- Group, 24-week Placebo-controlled Study With 28-week Extension to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO)","has_exemption":false,"start_date":"2020-10-27","completion_date":"2022-10-13","has_results":true,"results_due":true,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04626128","publication_url":"https://clinicaltrials.gov/study/NCT04626128","title":"OASIS: Open-label, Dose-escalation, Phase 1/2a Study of the Safety and Tolerability of Suprachoroidally Administered CLS-AX Following Intravitreal Anti-VEGF Therapy in Subjects With Neovascular Age-related Macular Degeneration","has_exemption":false,"start_date":"2020-12-15","completion_date":"2022-10-13","has_results":true,"results_due":true,"sponsor_name":"Clearside Biomedical, Inc.","sponsor_slug":"clearside-biomedical-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04940390","publication_url":"https://clinicaltrials.gov/study/NCT04940390","title":"A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine","has_exemption":false,"start_date":"2021-06-30","completion_date":"2022-10-13","has_results":true,"results_due":true,"sponsor_name":"Satsuma Pharmaceuticals, Inc.","sponsor_slug":"satsuma-pharmaceuticals-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04826965","publication_url":"https://clinicaltrials.gov/study/NCT04826965","title":"Does Negative Pressure Wound Therapy With Instillation Reduce the Bioburden of Infections of the Upper and Lower Extremity?","has_exemption":false,"start_date":"2021-08-01","completion_date":"2022-10-13","has_results":true,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05074498","publication_url":"https://clinicaltrials.gov/study/NCT05074498","title":"A Seamless Phase 1b/2a Double-blind, Randomized, Multiple Dose, Multi-center, Sequential Dose-escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of TB006 in Patients With Mild to Severe Alzheimer's Disease","has_exemption":false,"start_date":"2021-10-08","completion_date":"2022-10-13","has_results":true,"results_due":true,"sponsor_name":"TrueBinding, Inc.","sponsor_slug":"truebinding-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05177094","publication_url":"https://clinicaltrials.gov/study/NCT05177094","title":"Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain","has_exemption":false,"start_date":"2022-01-26","completion_date":"2022-10-13","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05263037","publication_url":"https://clinicaltrials.gov/study/NCT05263037","title":"A Decentralized, Randomized, Controlled Trial to Study Health Outcomes of EaseVRx-8w+ for the Treatment of Chronic Lower Back Pain","has_exemption":false,"start_date":"2022-01-31","completion_date":"2022-10-13","has_results":true,"results_due":true,"sponsor_name":"AppliedVR Inc.","sponsor_slug":"appliedvr-inc","status":"reported-late","is_pact":false,"days_late":41},{"registry_id":"NCT05128773","publication_url":"https://clinicaltrials.gov/study/NCT05128773","title":"A Randomized, Multicenter, Double-blind, Phase 3 Study of Amcenestrant (SAR439859) Versus Tamoxifen for the Treatment of Patients With Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative or Positive, Stage IIB-III Breast Cancer Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity","has_exemption":false,"start_date":"2022-02-17","completion_date":"2022-10-13","has_results":true,"results_due":true,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02259621","publication_url":"https://clinicaltrials.gov/study/NCT02259621","title":"Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable Non-Small-Cell Lung Cancer.","has_exemption":true,"start_date":"2014-09-30","completion_date":"2022-10-14","has_results":true,"results_due":true,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03733730","publication_url":"https://clinicaltrials.gov/study/NCT03733730","title":"Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs","has_exemption":false,"start_date":"2018-11-27","completion_date":"2022-10-14","has_results":true,"results_due":true,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03672747","publication_url":"https://clinicaltrials.gov/study/NCT03672747","title":"The Impact of Spontaneous Cortical Activity on Neural Oscillations and Behavioral Performance: Evidence From High-definition tDCS and MEG","has_exemption":false,"start_date":"2019-02-20","completion_date":"2022-10-14","has_results":true,"results_due":true,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"reported-late","is_pact":false,"days_late":39},{"registry_id":"NCT03247413","publication_url":"https://clinicaltrials.gov/study/NCT03247413","title":"Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation","has_exemption":false,"start_date":"2019-09-01","completion_date":"2022-10-14","has_results":true,"results_due":true,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04739306","publication_url":"https://clinicaltrials.gov/study/NCT04739306","title":"A Randomized, Active-Controlled, Double-Masked, Parallel-Group, Phase 3 Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema","has_exemption":false,"start_date":"2021-07-22","completion_date":"2022-10-14","has_results":true,"results_due":true,"sponsor_name":"Celltrion","sponsor_slug":"celltrion","status":"reported-late","is_pact":false,"days_late":4},{"registry_id":"NCT04988308","publication_url":"https://clinicaltrials.gov/study/NCT04988308","title":"A Phase 2a/2b, Multicenter, Randomized, Placebo and Active Comparator-controlled, Double-Blind, Dose-ranging Study to Evaluate the Safety and Efficacy of Bermekimab (JNJ-77474462) for the Treatment of Subjects With Moderate to Severe Hidradenitis Suppurativa","has_exemption":false,"start_date":"2021-10-12","completion_date":"2022-10-14","has_results":true,"results_due":true,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04877015","publication_url":"https://clinicaltrials.gov/study/NCT04877015","title":"Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease","has_exemption":false,"start_date":"2021-12-07","completion_date":"2022-10-14","has_results":false,"results_due":true,"sponsor_name":"Synergic Medical Technologies, Inc.","sponsor_slug":"synergic-medical-technologies-inc","status":"overdue","is_pact":false,"days_late":986},{"registry_id":"NCT05299892","publication_url":"https://clinicaltrials.gov/study/NCT05299892","title":"Optimizing Soft Speech Recognition in Children With Hearing Loss","has_exemption":false,"start_date":"2022-03-21","completion_date":"2022-10-14","has_results":true,"results_due":true,"sponsor_name":"Sonova AG","sponsor_slug":"sonova-ag","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02185417","publication_url":"https://clinicaltrials.gov/study/NCT02185417","title":"CSP #597 - Diuretic Comparison Project","has_exemption":false,"start_date":"2016-06-15","completion_date":"2022-10-15","has_results":true,"results_due":true,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03253913","publication_url":"https://clinicaltrials.gov/study/NCT03253913","title":"Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial (RESULT)","has_exemption":false,"start_date":"2018-03-31","completion_date":"2022-10-15","has_results":true,"results_due":true,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03986593","publication_url":"https://clinicaltrials.gov/study/NCT03986593","title":"Cone-beam Computed Tomography Guided Percutaneous Cryoablation of Bone Metastases From Endocrine Tumors","has_exemption":false,"start_date":"2019-09-26","completion_date":"2022-10-15","has_results":false,"results_due":true,"sponsor_name":"Instituto do Cancer do Estado de São Paulo","sponsor_slug":"instituto-do-cancer-do-estado-de-sao-paulo","status":"overdue","is_pact":false,"days_late":985},{"registry_id":"NCT04625673","publication_url":"https://clinicaltrials.gov/study/NCT04625673","title":"Phase 2, Randomized Study of the Tolerability and Safety of the OsciPulse Device for the Prevention of VTE","has_exemption":false,"start_date":"2021-05-12","completion_date":"2022-10-15","has_results":true,"results_due":true,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05013034","publication_url":"https://clinicaltrials.gov/study/NCT05013034","title":"Fort Worth Clinical Sciences Working Group (FWCSWG) for COVID-19: Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients","has_exemption":false,"start_date":"2021-10-15","completion_date":"2022-10-15","has_results":false,"results_due":true,"sponsor_name":"Fort Worth Clinical Sciences Working Group","sponsor_slug":"fort-worth-clinical-sciences-working-group","status":"overdue","is_pact":false,"days_late":985},{"registry_id":"NCT03819140","publication_url":"https://clinicaltrials.gov/study/NCT03819140","title":"Continuous Versus Cyclical OCP Use in PCOS: A Pilot Study","has_exemption":false,"start_date":"2019-04-01","completion_date":"2022-10-16","has_results":true,"results_due":true,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"reported-late","is_pact":false,"days_late":1},{"registry_id":"NCT04555044","publication_url":"https://clinicaltrials.gov/study/NCT04555044","title":"A Randomized, Double-Blind, Controlled, Clinical Trial to Evaluate the Risk of Developing Essential Fatty Acid Deficiency in Pediatric Patients, Including Neonates, Receiving Either Clinolipid (Lipid Injectable Emulsion, USP) 20% or Standard-of-Care Soybean Oil-Based Lipid Emulsion (Part A)","has_exemption":true,"start_date":"2021-01-22","completion_date":"2022-10-16","has_results":true,"results_due":true,"sponsor_name":"Baxter Healthcare Corporation","sponsor_slug":"baxter-healthcare-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02296528","publication_url":"https://clinicaltrials.gov/study/NCT02296528","title":"Safety and Efficacy of the Swallow Expansion Device (SED) for Improvement of Swallowing in Patients With Life-threatening Aspiration Secondary to Feeding Tube Dependent Oropharyngeal Dysphagia: A Single-site, Open-label, Phase 1 Human Trial","has_exemption":false,"start_date":"2014-06-30","completion_date":"2022-10-17","has_results":true,"results_due":true,"sponsor_name":"Peter Belafsky, MD","sponsor_slug":"peter-belafsky-md","status":"reported-late","is_pact":true,"days_late":61},{"registry_id":"NCT03043807","publication_url":"https://clinicaltrials.gov/study/NCT03043807","title":"A Phase II Study of Definitive Therapy for Newly Diagnosed Men With Oligometastatic Prostate Cancer After Prostatectomy","has_exemption":false,"start_date":"2017-02-22","completion_date":"2022-10-17","has_results":true,"results_due":true,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03534284","publication_url":"https://clinicaltrials.gov/study/NCT03534284","title":"Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis (Sleep-HD)","has_exemption":false,"start_date":"2018-09-19","completion_date":"2022-10-17","has_results":true,"results_due":true,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"reported-late","is_pact":false,"days_late":83},{"registry_id":"NCT03664232","publication_url":"https://clinicaltrials.gov/study/NCT03664232","title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Adolescent and Adult Subjects With Autism Spectrum Disorder","has_exemption":true,"start_date":"2018-11-07","completion_date":"2022-10-17","has_results":true,"results_due":true,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03889925","publication_url":"https://clinicaltrials.gov/study/NCT03889925","title":"Effect of Different Injection Regimens of Autologous Conditioned Plasma for the Treatment of Symptomatic Knee Osteoarthritis","has_exemption":false,"start_date":"2019-03-15","completion_date":"2022-10-17","has_results":true,"results_due":true,"sponsor_name":"Andrews Research & Education Foundation","sponsor_slug":"andrews-research-education-foundation","status":"reported-late","is_pact":false,"days_late":141},{"registry_id":"NCT03913195","publication_url":"https://clinicaltrials.gov/study/NCT03913195","title":"A Phase 3 Study of the Safety of Trogarzo® Administered as an Undiluted \"IV Push\" Over a Reduced Interval or as an Intramuscular Injection in Clinically Stable HIV-1 Infected Trogarzo® Experienced Patients and Healthy HIV-uninfected Volunteers","has_exemption":true,"start_date":"2019-05-30","completion_date":"2022-10-17","has_results":true,"results_due":true,"sponsor_name":"TaiMed Biologics Inc.","sponsor_slug":"taimed-biologics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04414397","publication_url":"https://clinicaltrials.gov/study/NCT04414397","title":"A Multicenter, Evaluator-blinded, Randomized, Parallel-group, Controlled Study of the Safety and Effectiveness of JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing","has_exemption":true,"start_date":"2020-05-28","completion_date":"2022-10-17","has_results":true,"results_due":true,"sponsor_name":"Allergan","sponsor_slug":"allergan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04544865","publication_url":"https://clinicaltrials.gov/study/NCT04544865","title":"A Prospective, Single-Arm, Multi-Center Study of the ECHELON ENDOPATH(TM) Staple Line Reinforcement Device in Gastric and Lung Resection Procedures","has_exemption":false,"start_date":"2020-09-29","completion_date":"2022-10-17","has_results":true,"results_due":true,"sponsor_name":"Ethicon Endo-Surgery","sponsor_slug":"ethicon-endo-surgery","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04598295","publication_url":"https://clinicaltrials.gov/study/NCT04598295","title":"A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Impact of a Multi-strain Synbiotic on Fecal Metagenomic Stability, Gut Barrier Integrity, and Metabolic Output of the Gut Microbiota","has_exemption":false,"start_date":"2020-10-20","completion_date":"2022-10-17","has_results":true,"results_due":true,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"reported-late","is_pact":false,"days_late":601},{"registry_id":"NCT04456998","publication_url":"https://clinicaltrials.gov/study/NCT04456998","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Clinical Study to Evaluate the Efficacy and Safety of Oral Inhalation of GB002 for the Treatment of WHO Group 1 Pulmonary Arterial Hypertension (PAH)","has_exemption":false,"start_date":"2020-11-12","completion_date":"2022-10-17","has_results":true,"results_due":true,"sponsor_name":"GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.","sponsor_slug":"gb002-inc-a-wholly-owned-subsidiary-of-gossamer-bio-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04595058","publication_url":"https://clinicaltrials.gov/study/NCT04595058","title":"Multicenter, Randomized and Comparative Study of Lumen-apposing Metal Stents With or Without Coaxial Plastic Stent for Endoscopic Ultrasound-guided Transmural Biliary Drainage","has_exemption":false,"start_date":"2020-11-17","completion_date":"2022-10-17","has_results":false,"results_due":true,"sponsor_name":"Hospital Universitari de Bellvitge","sponsor_slug":"hospital-universitari-de-bellvitge","status":"overdue","is_pact":false,"days_late":983},{"registry_id":"NCT05271708","publication_url":"https://clinicaltrials.gov/study/NCT05271708","title":"Explore the Short- and Mid-term Effects of Fespixon in Scar Cosmesis Following Cervical or Abdominal Surgery","has_exemption":false,"start_date":"2022-01-05","completion_date":"2022-10-17","has_results":false,"results_due":true,"sponsor_name":"National Defense Medical Center, Taiwan","sponsor_slug":"national-defense-medical-center-taiwan","status":"overdue","is_pact":false,"days_late":983},{"registry_id":"NCT05243628","publication_url":"https://clinicaltrials.gov/study/NCT05243628","title":"ABC [Afrezza With Basal Combination]: A Phase 4 Study of Mealtime Control With Afrezza in Adult Subjects With Type 1 Diabetes Mellitus in Combination With an Automated Insulin Pump or Insulin Degludec","has_exemption":false,"start_date":"2022-03-31","completion_date":"2022-10-17","has_results":true,"results_due":true,"sponsor_name":"Mannkind Corporation","sponsor_slug":"mannkind-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05098067","publication_url":"https://clinicaltrials.gov/study/NCT05098067","title":"Trial of Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy: A Pilot Investigation","has_exemption":false,"start_date":"2022-05-24","completion_date":"2022-10-17","has_results":true,"results_due":true,"sponsor_name":"Women and Infants Hospital of Rhode Island","sponsor_slug":"women-and-infants-hospital-of-rhode-island","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05502289","publication_url":"https://clinicaltrials.gov/study/NCT05502289","title":"Clinical Evaluation of Delefilcon A and Verofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of Wear","has_exemption":false,"start_date":"2022-08-19","completion_date":"2022-10-17","has_results":true,"results_due":true,"sponsor_name":"Johnson & Johnson Vision Care, Inc.","sponsor_slug":"johnson-johnson-vision-care-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03237286","publication_url":"https://clinicaltrials.gov/study/NCT03237286","title":"Testing a Synergistic, Neuroplasticity-Based Intervention for Depressive Neurocognition","has_exemption":false,"start_date":"2017-12-01","completion_date":"2022-10-18","has_results":true,"results_due":true,"sponsor_name":"Rebecca Price","sponsor_slug":"rebecca-price","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03562507","publication_url":"https://clinicaltrials.gov/study/NCT03562507","title":"ERICA: Phase 2 Multi-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell Carcinoma","has_exemption":false,"start_date":"2019-04-11","completion_date":"2022-10-18","has_results":true,"results_due":true,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03736720","publication_url":"https://clinicaltrials.gov/study/NCT03736720","title":"Phase 2 Single-Arm Study of Nanoliposomal Irinotecan With Fluorouracil and Leucovorin in Refractory Advanced High Grade Neuroendocrine Cancer of GI, Unknown or Pancreatic Origin","has_exemption":false,"start_date":"2019-06-17","completion_date":"2022-10-18","has_results":true,"results_due":true,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04227106","publication_url":"https://clinicaltrials.gov/study/NCT04227106","title":"VIITAL: A Phase 3 Study of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)","has_exemption":false,"start_date":"2020-01-10","completion_date":"2022-10-18","has_results":false,"results_due":true,"sponsor_name":"Abeona Therapeutics, Inc","sponsor_slug":"abeona-therapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05137067","publication_url":"https://clinicaltrials.gov/study/NCT05137067","title":"Effectiveness of RaproCell in Alleviating the Side Effects of Chemotherapeutic Agents, Without Adversely Impacting the Overall Success of the Agents on Cancer Cells.","has_exemption":false,"start_date":"2021-01-20","completion_date":"2022-10-18","has_results":false,"results_due":true,"sponsor_name":"Optimal Health Research","sponsor_slug":"optimal-health-research","status":"overdue","is_pact":false,"days_late":982},{"registry_id":"NCT04492488","publication_url":"https://clinicaltrials.gov/study/NCT04492488","title":"An Open-Label, Multi-center Phase I/II Dose Escalation and Expansion Study to Assess the Safety, Efficacy and Pharmacokinetics of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer","has_exemption":false,"start_date":"2021-05-24","completion_date":"2022-10-18","has_results":false,"results_due":true,"sponsor_name":"Shanghai Miracogen Inc.","sponsor_slug":"shanghai-miracogen-inc","status":"overdue","is_pact":false,"days_late":982},{"registry_id":"NCT04928820","publication_url":"https://clinicaltrials.gov/study/NCT04928820","title":"Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT With 99mTc-MDP Bone Scan and CT for Detection of M1b Disease in Prostate Cancer Patients With Biochemical Progression During ADT","has_exemption":false,"start_date":"2021-06-16","completion_date":"2022-10-18","has_results":false,"results_due":true,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"reported-late","is_pact":false,"days_late":271}]}